BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu J, Jiao Y, Dal Molin M, Maitra A, de Wilde RF, Wood LD, Eshleman JR, Goggins MG, Wolfgang CL, Canto MI, Schulick RD, Edil BH, Choti MA, Adsay V, Klimstra DS, Offerhaus GJ, Klein AP, Kopelovich L, Carter H, Karchin R, Allen PJ, Schmidt CM, Naito Y, Diaz LA Jr, Kinzler KW, Papadopoulos N, Hruban RH, Vogelstein B. Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways. Proc Natl Acad Sci U S A 2011;108:21188-93. [PMID: 22158988 DOI: 10.1073/pnas.1118046108] [Cited by in Crossref: 437] [Cited by in F6Publishing: 368] [Article Influence: 39.7] [Reference Citation Analysis]
Number Citing Articles
1 Guerra C, Barbacid M. Genetically engineered mouse models of pancreatic adenocarcinoma. Mol Oncol 2013;7:232-47. [PMID: 23506980 DOI: 10.1016/j.molonc.2013.02.002] [Cited by in Crossref: 102] [Cited by in F6Publishing: 93] [Article Influence: 11.3] [Reference Citation Analysis]
2 Fujikura K, Akita M, Abe-suzuki S, Itoh T, Zen Y. Mucinous cystic neoplasms of the liver and pancreas: relationship between KRAS driver mutations and disease progression. Histopathology 2017;71:591-600. [DOI: 10.1111/his.13271] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 3.6] [Reference Citation Analysis]
3 Canto MI, Hruban RH. Diagnosis: A step closer to screening for curable pancreatic cancer? Nat Rev Gastroenterol Hepatol 2015;12:431-2. [PMID: 26122477 DOI: 10.1038/nrgastro.2015.112] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
4 Doi T, Hojo H, Ohba S, Obayashi K, Endo M, Ishizaki T, Katoh A, Kouji H. Involvement of activator protein-1 family members in β-catenin and p300 association on the genome of PANC-1 cells. Heliyon 2022;8:e08890. [DOI: 10.1016/j.heliyon.2022.e08890] [Reference Citation Analysis]
5 Rishi A, Goggins M, Wood LD, Hruban RH. Pathological and molecular evaluation of pancreatic neoplasms. Semin Oncol. 2015;42:28-39. [PMID: 25726050 DOI: 10.1053/j.seminoncol.2014.12.004] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 4.9] [Reference Citation Analysis]
6 Zhou D, Yang L, Zheng L, Ge W, Li D, Zhang Y, Hu X, Gao Z, Xu J, Huang Y. Exome capture sequencing of adenoma reveals genetic alterations in multiple cellular pathways at the early stage of colorectal tumorigenesis. PLoS One. 2013;8:e53310. [PMID: 23301059 DOI: 10.1371/journal.pone.0053310] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
7 Rebours V, Le Faouder J, Laouirem S, Mebarki M, Albuquerque M, Camadro JM, Léger T, Ruszniewski P, Lévy P, Paradis V, Bedossa P, Couvelard A. In situ proteomic analysis by MALDI imaging identifies ubiquitin and thymosin-β4 as markers of malignant intraductal pancreatic mucinous neoplasms. Pancreatology 2014;14:117-24. [PMID: 24650966 DOI: 10.1016/j.pan.2013.12.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
8 Law JK, Hruban RH, Lennon AM. Management of pancreatic cysts: a multidisciplinary approach. Curr Opin Gastroenterol. 2013;29:509-516. [PMID: 23872487 DOI: 10.1097/mog.0b013e328363e3b3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
9 Solcia E, Necchi V, Sommi P, Ricci V. Proteasome-Rich PaCS as an Oncofetal UPS Structure Handling Cytosolic Polyubiquitinated Proteins. In Vivo Occurrence, in Vitro Induction, and Biological Role. Int J Mol Sci 2018;19:E2767. [PMID: 30223470 DOI: 10.3390/ijms19092767] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Fujita M, Matsubara N, Matsuda I, Maejima K, Oosawa A, Yamano T, Fujimoto A, Furuta M, Nakano K, Oku-Sasaki A, Tanaka H, Shiraishi Y, Mateos RN, Nakai K, Miyano S, Tomita N, Hirota S, Ikeuchi H, Nakagawa H. Genomic landscape of colitis-associated cancer indicates the impact of chronic inflammation and its stratification by mutations in the Wnt signaling. Oncotarget 2018;9:969-81. [PMID: 29416670 DOI: 10.18632/oncotarget.22867] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
11 Chelliah A, Kalimuthu S, Chetty R. Intraductal tubular neoplasms of the pancreas: an overview. Annals of Diagnostic Pathology 2016;24:68-72. [DOI: 10.1016/j.anndiagpath.2016.04.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
12 Felsenstein M, Hruban RH, Wood LD. New Developments in the Molecular Mechanisms of Pancreatic Tumorigenesis. Adv Anat Pathol. 2018;25:131-142. [PMID: 28914620 DOI: 10.1097/pap.0000000000000172] [Cited by in Crossref: 25] [Cited by in F6Publishing: 14] [Article Influence: 6.3] [Reference Citation Analysis]
13 Riva G, Pea A, Pilati C, Fiadone G, Lawlor RT, Scarpa A, Luchini C. Histo-molecular oncogenesis of pancreatic cancer: From precancerous lesions to invasive ductal adenocarcinoma. World J Gastrointest Oncol 2018; 10(10): 317-327 [PMID: 30364837 DOI: 10.4251/wjgo.v10.i10.317] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
14 Aguilera KY, Dawson DW. WNT Ligand Dependencies in Pancreatic Cancer. Front Cell Dev Biol 2021;9:671022. [PMID: 33996827 DOI: 10.3389/fcell.2021.671022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Scourtas A, Dudley JC, Brugge WR, Kadayifci A, Mino-Kenudson M, Pitman MB. Preoperative characteristics and cytological features of 136 histologically confirmed pancreatic mucinous cystic neoplasms. Cancer Cytopathol 2017;125:169-77. [PMID: 27926784 DOI: 10.1002/cncy.21806] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
16 Reid MD, Choi H, Balci S, Akkas G, Adsay V. Serous cystic neoplasms of the pancreas: clinicopathologic and molecular characteristics. Semin Diagn Pathol. 2014;31:475-483. [PMID: 25441309 DOI: 10.1053/j.semdp.2014.08.009] [Cited by in Crossref: 46] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
17 Rape M. Ubiquitylation at the crossroads of development and disease. Nat Rev Mol Cell Biol 2018;19:59-70. [PMID: 28928488 DOI: 10.1038/nrm.2017.83] [Cited by in Crossref: 189] [Cited by in F6Publishing: 179] [Article Influence: 37.8] [Reference Citation Analysis]
18 Nista EC, Schepis T, Candelli M, Giuli L, Pignataro G, Franceschi F, Gasbarrini A, Ojetti V. Humoral Predictors of Malignancy in IPMN: A Review of the Literature. Int J Mol Sci 2021;22:12839. [PMID: 34884643 DOI: 10.3390/ijms222312839] [Reference Citation Analysis]
19 Chang XY, Wu Y, Jiang Y, Wang PY, Chen J. RNF43 Mutations in IPMN Cases: A Potential Prognostic Factor. Gastroenterol Res Pract 2020;2020:1457452. [PMID: 32934653 DOI: 10.1155/2020/1457452] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Wong CC, Martincorena I, Rust AG, Rashid M, Alifrangis C, Alexandrov LB, Tiffen JC, Kober C, Green AR, Massie CE, Nangalia J, Lempidaki S, Döhner H, Döhner K, Bray SJ, McDermott U, Papaemmanuil E, Campbell PJ, Adams DJ; Chronic Myeloid Disorders Working Group of the International Cancer Genome Consortium. Inactivating CUX1 mutations promote tumorigenesis. Nat Genet 2014;46:33-8. [PMID: 24316979 DOI: 10.1038/ng.2846] [Cited by in Crossref: 78] [Cited by in F6Publishing: 73] [Article Influence: 8.7] [Reference Citation Analysis]
21 Saiki Y, Horii A. Molecular pathology of pancreatic cancer. Pathol Int 2014;64:10-9. [PMID: 24471965 DOI: 10.1111/pin.12114] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
22 Freeny PC, Saunders MD. Moving beyond morphology: new insights into the characterization and management of cystic pancreatic lesions. Radiology. 2014;272:345-363. [PMID: 25058133 DOI: 10.1148/radiol.14131126] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 3.9] [Reference Citation Analysis]
23 von Figura G, Fukuda A, Roy N, Liku ME, Morris Iv JP, Kim GE, Russ HA, Firpo MA, Mulvihill SJ, Dawson DW, Ferrer J, Mueller WF, Busch A, Hertel KJ, Hebrok M. The chromatin regulator Brg1 suppresses formation of intraductal papillary mucinous neoplasm and pancreatic ductal adenocarcinoma. Nat Cell Biol 2014;16:255-67. [PMID: 24561622 DOI: 10.1038/ncb2916] [Cited by in Crossref: 122] [Cited by in F6Publishing: 102] [Article Influence: 15.3] [Reference Citation Analysis]
24 Rouanet M, Lebrin M, Gross F, Bournet B, Cordelier P, Buscail L. Gene Therapy for Pancreatic Cancer: Specificity, Issues and Hopes. Int J Mol Sci 2017;18:E1231. [PMID: 28594388 DOI: 10.3390/ijms18061231] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
25 Tan MC, Basturk O, Brannon AR, Bhanot U, Scott SN, Bouvier N, LaFemina J, Jarnagin WR, Berger MF, Klimstra D, Allen PJ. GNAS and KRAS Mutations Define Separate Progression Pathways in Intraductal Papillary Mucinous Neoplasm-Associated Carcinoma. J Am Coll Surg 2015; 220: 845-854. e1. [PMID: 25840541 DOI: 10.1016/j.jamcollsurg.2014.11.029] [Cited by in Crossref: 107] [Cited by in F6Publishing: 92] [Article Influence: 15.3] [Reference Citation Analysis]
26 Kamisawa T, Wood LD, Itoi T, Takaori K. Pancreatic cancer. Lancet. 2016;388:73-85. [PMID: 26830752 DOI: 10.1016/s0140-6736(16)00141-0] [Cited by in Crossref: 995] [Cited by in F6Publishing: 643] [Article Influence: 165.8] [Reference Citation Analysis]
27 Oldfield LE, Connor AA, Gallinger S. Molecular Events in the Natural History of Pancreatic Cancer. Trends Cancer 2017;3:336-46. [PMID: 28718411 DOI: 10.1016/j.trecan.2017.04.005] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 6.6] [Reference Citation Analysis]
28 Thu KL, Radulovich N, Becker-Santos DD, Pikor LA, Pusic A, Lockwood WW, Lam WL, Tsao MS. SOX15 is a candidate tumor suppressor in pancreatic cancer with a potential role in Wnt/β-catenin signaling. Oncogene. 2014;33:279-288. [PMID: 23318427 DOI: 10.1038/onc.2012.595] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 4.6] [Reference Citation Analysis]
29 Hruban RH, Klimstra DS, Zamboni G, Klöppel G. A semicentennial of pancreatic pathology: the genetic revolution is here, but don't throw the baby out with the bath water! Hum Pathol 2020;95:99-112. [PMID: 31521627 DOI: 10.1016/j.humpath.2019.08.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
30 Leung C, Tan SH, Barker N. Recent Advances in Lgr5 + Stem Cell Research. Trends in Cell Biology 2018;28:380-91. [DOI: 10.1016/j.tcb.2018.01.010] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 13.5] [Reference Citation Analysis]
31 Neumeyer V, Grandl M, Dietl A, Brutau-abia A, Allgäuer M, Kalali B, Zhang Y, Pan K, Steiger K, Vieth M, Anton M, Mejías-luque R, Gerhard M. Loss of endogenous RNF43 function enhances proliferation and tumour growth of intestinal and gastric cells. Carcinogenesis 2019;40:551-9. [DOI: 10.1093/carcin/bgy152] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
32 Wolfgang CL, Herman JM, Laheru DA, Klein AP, Erdek MA, Fishman EK, Hruban RH. Recent progress in pancreatic cancer. CA Cancer J Clin. 2013;63:318-348. [PMID: 23856911 DOI: 10.3322/caac.21190] [Cited by in Crossref: 479] [Cited by in F6Publishing: 473] [Article Influence: 53.2] [Reference Citation Analysis]
33 Wood LD, Yurgelun MB, Goggins MG. Genetics of Familial and Sporadic Pancreatic Cancer. Gastroenterology 2019;156:2041-55. [PMID: 30660730 DOI: 10.1053/j.gastro.2018.12.039] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 8.7] [Reference Citation Analysis]
34 Neuzillet C, Tijeras-Raballand A, Bourget P, Cros J, Couvelard A, Sauvanet A, Vullierme MP, Tournigand C, Hammel P. State of the art and future directions of pancreatic ductal adenocarcinoma therapy. Pharmacol Ther. 2015;155:80-104. [PMID: 26299994 DOI: 10.1016/j.pharmthera.2015.08.006] [Cited by in Crossref: 58] [Cited by in F6Publishing: 57] [Article Influence: 8.3] [Reference Citation Analysis]
35 Singhi AD, George B, Greenbowe JR, Chung J, Suh J, Maitra A, Klempner SJ, Hendifar A, Milind JM, Golan T, Brand RE, Zureikat AH, Roy S, Schrock AB, Miller VA, Ross JS, Ali SM, Bahary N. Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers. Gastroenterology 2019;156:2242-2253.e4. [DOI: 10.1053/j.gastro.2019.02.037] [Cited by in Crossref: 81] [Cited by in F6Publishing: 78] [Article Influence: 27.0] [Reference Citation Analysis]
36 Amato E, Mafficini A, Hirabayashi K, Lawlor RT, Fassan M, Vicentini C, Barbi S, Delfino P, Sikora K, Rusev B, Simbolo M, Esposito I, Antonello D, Pea A, Sereni E, Ballotta M, Maggino L, Marchegiani G, Ohike N, Wood LD, Salvia R, Klöppel G, Zamboni G, Scarpa A, Corbo V. Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas. J Pathol 2019;247:123-34. [PMID: 30306561 DOI: 10.1002/path.5180] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
37 Ivry SL, Knudsen GM, Caiazza F, Sharib JM, Jaradeh K, Ravalin M, O’donoghue AJ, Kirkwood KS, Craik CS. The lysosomal aminopeptidase tripeptidyl peptidase 1 displays increased activity in malignant pancreatic cysts. Biological Chemistry 2019;400:1629-38. [DOI: 10.1515/hsz-2019-0103] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
38 van Andel H, Ren Z, Koopmans I, Joosten SP, Kocemba KA, de Lau W, Kersten MJ, de Bruin AM, Guikema JE, Clevers H, Spaargaren M, Pals ST. Aberrantly expressed LGR4 empowers Wnt signaling in multiple myeloma by hijacking osteoblast-derived R-spondins. Proc Natl Acad Sci U S A 2017;114:376-81. [PMID: 28028233 DOI: 10.1073/pnas.1618650114] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
39 Serra S, Chetty R. Rnf43. J Clin Pathol 2018;71:1-6. [PMID: 29018044 DOI: 10.1136/jclinpath-2017-204763] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
40 Wang SC, Nassour I, Xiao S, Zhang S, Luo X, Lee J, Li L, Sun X, Nguyen LH, Chuang JC, Peng L, Daigle S, Shen J, Zhu H. SWI/SNF component ARID1A restrains pancreatic neoplasia formation. Gut 2019;68:1259-70. [PMID: 30315093 DOI: 10.1136/gutjnl-2017-315490] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
41 Chiaro MD, Segersvärd R, Lohr M, Verbeke C. Early detection and prevention of pancreatic cancer: Is it really possible today? World J Gastroenterol 2014; 20(34): 12118-12131 [PMID: 25232247 DOI: 10.3748/wjg.v20.i34.12118] [Cited by in CrossRef: 73] [Cited by in F6Publishing: 60] [Article Influence: 9.1] [Reference Citation Analysis]
42 Yoon WJ, Bishop Pitman M. Cytology Specimen Management, Triage and Standardized Reporting of Fine Needle Aspiration Biopsies of the Pancreas. J Pathol Transl Med 2015;49:364-72. [PMID: 26265683 DOI: 10.4132/jptm.2015.07.19] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
43 Zhou X, Sun Z, Zhang M, Qu X, Yang S, Wang L, Jing Y, Li L, Deng W, Liu F, Di J, Chen J, Wu J, Zhang H. Deficient Rnf43 potentiates hyperactive Kras‐mediated pancreatic preneoplasia initiation and malignant transformation. Anim Models and Exp Med. [DOI: 10.1002/ame2.12203] [Reference Citation Analysis]
44 Gaujoux S, Pasmant E, Silve C, Mehsen-Cetre N, Coriat R, Rouquette A, Douset B, Prat F, Leroy K. McCune Albright syndrome is a genetic predisposition to intraductal papillary and mucinous neoplasms of the pancreas associated pancreatic cancer in relation with GNAS somatic mutation - a case report. Medicine (Baltimore) 2019;98:e18102. [PMID: 31852070 DOI: 10.1097/MD.0000000000018102] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
45 Wood LD, Hruban RH. Genomic landscapes of pancreatic neoplasia. J Pathol Transl Med 2015;49:13-22. [PMID: 25812653 DOI: 10.4132/jptm.2014.12.26] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
46 Iacobuzio-Donahue CA, Velculescu VE, Wolfgang CL, Hruban RH. Genetic basis of pancreas cancer development and progression: insights from whole-exome and whole-genome sequencing. Clin Cancer Res. 2012;18:4257-4265. [PMID: 22896692 DOI: 10.1158/1078-0432.ccr-12-0315] [Cited by in Crossref: 85] [Cited by in F6Publishing: 53] [Article Influence: 9.4] [Reference Citation Analysis]
47 Schmidt CM, Pitman MB. Pancreatic cyst cytology: Optimization of cancer risk profiling: To highlight the impact of cytopathology on patient management and treatment. Cancer Cytopathology 2013;121:2-3. [DOI: 10.1002/cncy.21267] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
48 Heller A, Angelova AL, Bauer S, Grekova SP, Aprahamian M, Rommelaere J, Volkmar M, Janssen JW, Bauer N, Herr I, Giese T, Gaida MM, Bergmann F, Hackert T, Fritz S, Giese NA. Establishment and Characterization of a Novel Cell Line, ASAN-PaCa, Derived From Human Adenocarcinoma Arising in Intraductal Papillary Mucinous Neoplasm of the Pancreas. Pancreas 2016;45:1452-60. [PMID: 27518460 DOI: 10.1097/MPA.0000000000000673] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
49 Chin JY, Pitman MB, Hong TS. Intraductal papillary mucinous neoplasm: clinical surveillance and management decisions. Semin Radiat Oncol. 2014;24:77-84. [PMID: 24635864 DOI: 10.1016/j.semradonc.2013.11.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
50 Rapetti-Mauss R, Berenguier C, Allegrini B, Soriani O. Interplay Between Ion Channels and the Wnt/β-Catenin Signaling Pathway in Cancers. Front Pharmacol 2020;11:525020. [PMID: 33117152 DOI: 10.3389/fphar.2020.525020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
51 Yoshida K, Nagasaka T, Umeda Y, Tanaka T, Kimura K, Taniguchi F, Fuji T, Shigeyasu K, Mori Y, Yanai H, Yagi T, Goel A, Fujiwara T. Expansion of epigenetic alterations in EFEMP1 promoter predicts malignant formation in pancreatobiliary intraductal papillary mucinous neoplasms. J Cancer Res Clin Oncol 2016;142:1557-69. [PMID: 27095449 DOI: 10.1007/s00432-016-2164-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
52 Ryland GL, Hunter SM, Doyle MA, Rowley SM, Christie M, Allan PE, Bowtell DD, Gorringe KL, Campbell IG. RNF43 is a tumour suppressor gene mutated in mucinous tumours of the ovary. J Pathol. 2013;229:469-476. [PMID: 23096461 DOI: 10.1002/path.4134] [Cited by in Crossref: 76] [Cited by in F6Publishing: 69] [Article Influence: 8.4] [Reference Citation Analysis]
53 Imai K, Karasaki H, Ono Y, Sasajima J, Chiba S, Funakoshi H, Muraki M, Hanaoka H, Furukawa T, Furukawa H, Kono T, Nagashima K, Mizukami Y. Metachronous pancreatic cancer originating from disseminated founder pancreatic intraductal neoplasias (PanINs). J Pathol Clin Res 2015;1:76-82. [PMID: 27499895 DOI: 10.1002/cjp2.8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
54 Ngamruengphong S, Lennon AM. Analysis of Pancreatic Cyst Fluid. Surg Pathol Clin 2016;9:677-84. [PMID: 27926366 DOI: 10.1016/j.path.2016.05.010] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
55 Singhi AD, Zeh HJ, Brand RE, Nikiforova MN, Chennat JS, Fasanella KE, Khalid A, Papachristou GI, Slivka A, Hogg M, Lee KK, Tsung A, Zureikat AH, McGrath K. American Gastroenterological Association guidelines are inaccurate in detecting pancreatic cysts with advanced neoplasia: a clinicopathologic study of 225 patients with supporting molecular data. Gastrointest Endosc 2016;83:1107-1117.e2. [PMID: 26709110 DOI: 10.1016/j.gie.2015.12.009] [Cited by in Crossref: 106] [Cited by in F6Publishing: 81] [Article Influence: 15.1] [Reference Citation Analysis]
56 Kubota Y, Kawakami H, Natsuizaka M, Kawakubo K, Marukawa K, Kudo T, Abe Y, Kubo K, Kuwatani M, Hatanaka Y, Mitsuhashi T, Matsuno Y, Sakamoto N. CTNNB1 mutational analysis of solid-pseudopapillary neoplasms of the pancreas using endoscopic ultrasound-guided fine-needle aspiration and next-generation deep sequencing. J Gastroenterol. 2015;50:203-210. [PMID: 24700283 DOI: 10.1007/s00535-014-0954-y] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
57 Zhang XP, Yu ZX, Zhao YP, Dai MH. Current perspectives on pancreatic serous cystic neoplasms: Diagnosis, management and beyond. World J Gastrointest Surg 2016; 8(3): 202-211 [PMID: 27022447 DOI: 10.4240/wjgs.v8.i3.202] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
58 Bernard V, Fleming J, Maitra A. Molecular and Genetic Basis of Pancreatic Carcinogenesis. Surgical Oncology Clinics of North America 2016;25:227-38. [DOI: 10.1016/j.soc.2015.11.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
59 Singhi AD, Lilo M, Hruban RH, Cressman KL, Fuhrer K, Seethala RR. Overexpression of lymphoid enhancer-binding factor 1 (LEF1) in solid-pseudopapillary neoplasms of the pancreas. Mod Pathol. 2014;27:1355-1363. [PMID: 24658583 DOI: 10.1038/modpathol.2014.40] [Cited by in Crossref: 43] [Cited by in F6Publishing: 32] [Article Influence: 5.4] [Reference Citation Analysis]
60 Brewer Gutierrez OI, Lennon AM. Pancreatic Cysts: Sinister Findings or Incidentalomas? Med Clin North Am 2019;103:163-72. [PMID: 30466673 DOI: 10.1016/j.mcna.2018.08.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
61 Hashimoto T, Yamashita S, Yoshida H, Taniguchi H, Ushijima T, Yamada T, Saito Y, Ochiai A, Sekine S, Hiraoka N. WNT Pathway Gene Mutations Are Associated With the Presence of Dysplasia in Colorectal Sessile Serrated Adenoma/Polyps. Am J Surg Pathol. 2017;41:1188-1197. [PMID: 28614199 DOI: 10.1097/pas.0000000000000877] [Cited by in Crossref: 40] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
62 Kanda M, Knight S, Topazian M, Syngal S, Farrell J, Lee J, Kamel I, Lennon AM, Borges M, Young A. Mutant GNAS detected in duodenal collections of secretin-stimulated pancreatic juice indicates the presence or emergence of pancreatic cysts. Gut. 2013;62:1024-1033. [PMID: 22859495 DOI: 10.1136/gutjnl-2012-302823] [Cited by in Crossref: 119] [Cited by in F6Publishing: 107] [Article Influence: 11.9] [Reference Citation Analysis]
63 Xu L, Lin W, Wen L, Li G. Lgr5 in cancer biology: functional identification of Lgr5 in cancer progression and potential opportunities for novel therapy. Stem Cell Res Ther 2019;10:219. [PMID: 31358061 DOI: 10.1186/s13287-019-1288-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
64 Omori Y, Ono Y, Tanino M, Karasaki H, Yamaguchi H, Furukawa T, Enomoto K, Ueda J, Sumi A, Katayama J, Muraki M, Taniue K, Takahashi K, Ambo Y, Shinohara T, Nishihara H, Sasajima J, Maguchi H, Mizukami Y, Okumura T, Tanaka S. Pathways of Progression From Intraductal Papillary Mucinous Neoplasm to Pancreatic Ductal Adenocarcinoma Based on Molecular Features. Gastroenterology 2019; 156: 647-661. e2. [PMID: 30342036 DOI: 10.1053/j.gastro.2018.10.029] [Cited by in Crossref: 58] [Cited by in F6Publishing: 54] [Article Influence: 14.5] [Reference Citation Analysis]
65 Deftereos G, Finkelstein SD, Jackson SA, Ellsworth EM, Krishnamurti U, Liu Y, Silverman JF, Binkert CR, Ujevich BA, Mohanty A. The value of mutational profiling of the cytocentrifugation supernatant fluid from fine-needle aspiration of pancreatic solid mass lesions. Mod Pathol 2014;27:594-601. [DOI: 10.1038/modpathol.2013.147] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
66 Takano S, Fukasawa M, Kadokura M, Shindo H, Takahashi E, Hirose S, Fukasawa Y, Kawakami S, Hayakawa H, Maekawa S, Mochizuki K, Kawaida H, Kono H, Itakura J, Sato T, Ichikawa D, Enomoto N. Mutational Patterns in Pancreatic Juice of Intraductal Papillary Mucinous Neoplasms and Concomitant Pancreatic Cancer. Pancreas 2019;48:1032-40. [DOI: 10.1097/mpa.0000000000001371] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
67 Italian Association of Hospital Gastroenterologists and Endoscopists, Italian Association for the Study of the Pancreas, Cystic Pancreatic Neoplasm Study Group; Buscarini E, Pezzilli R, Cannizzaro R, De Angelis C, Gion M, Morana G, Zamboni G, Arcidiacono P, Balzano G, Barresi L, Basso D, Bocus P, Calculli L, Capurso G, Canzonieri V, Casadei R, Crippa S, D'Onofrio M, Frulloni L, Fusaroli P, Manfredi G, Pacchioni D, Pasquali C, Rocca R, Ventrucci M, Venturini S, Villanacci V, Zerbi A, Falconi M. Italian consensus guidelines for the diagnostic work-up and follow-up of cystic pancreatic neoplasms. Dig Liver Dis. 2014;46:479-493. [PMID: 24809235 DOI: 10.1016/j.dld.2013.12.019] [Cited by in Crossref: 74] [Cited by in F6Publishing: 67] [Article Influence: 9.3] [Reference Citation Analysis]
68 Hruban RH, Klimstra DS. Adenocarcinoma of the pancreas. Semin Diagn Pathol 2014;31:443-51. [PMID: 25441308 DOI: 10.1053/j.semdp.2014.08.004] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 3.1] [Reference Citation Analysis]
69 Perkail S, Andricovich J, Kai Y, Tzatsos A. BAP1 is a haploinsufficient tumor suppressor linking chronic pancreatitis to pancreatic cancer in mice. Nat Commun 2020;11:3018. [PMID: 32541668 DOI: 10.1038/s41467-020-16589-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
70 Del Chiaro M, Verbeke C. Intraductal papillary mucinous neoplasms of the pancreas: reporting clinically relevant features. Histopathology 2017;70:850-60. [PMID: 27878841 DOI: 10.1111/his.13131] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
71 Hao HX, Xie Y, Zhang Y, Charlat O, Oster E, Avello M, Lei H, Mickanin C, Liu D, Ruffner H. ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner. Nature. 2012;485:195-200. [PMID: 22575959 DOI: 10.1038/nature11019] [Cited by in Crossref: 544] [Cited by in F6Publishing: 507] [Article Influence: 54.4] [Reference Citation Analysis]
72 Zhang ML, Pitman MB. Practical Applications of Molecular Testing in the Cytologic Diagnosis of Pancreatic Cysts. JMP 2021;2:11-22. [DOI: 10.3390/jmp2010002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Ceyhan GO, Scheufele F, Friess H. [Resection of main duct and mixed type IPMN ≥5 mm]. Chirurg 2017;88:913-7. [PMID: 28842734 DOI: 10.1007/s00104-017-0494-0] [Reference Citation Analysis]
74 Tsai J, Liau J, Yuan C, Lin Y, Tseng L, Cheng M, Jeng Y. RNF43 Is an Early and Specific Mutated Gene in the Serrated Pathway, With Increased Frequency in Traditional Serrated Adenoma and Its Associated Malignancy. American Journal of Surgical Pathology 2016;40:1352-9. [DOI: 10.1097/pas.0000000000000664] [Cited by in Crossref: 24] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
75 Fonseca AL, Kirkwood K, Kim MP, Maitra A, Koay EJ. Intraductal Papillary Mucinous Neoplasms of the Pancreas: Current Understanding and Future Directions for Stratification of Malignancy Risk. Pancreas. 2018;47:272-279. [PMID: 29424809 DOI: 10.1097/mpa.0000000000000999] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
76 Koo BK, Spit M, Jordens I, Low TY, Stange DE, van de Wetering M, van Es JH, Mohammed S, Heck AJ, Maurice MM. Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors. Nature. 2012;488:665-669. [PMID: 22895187 DOI: 10.1038/nature11308] [Cited by in Crossref: 534] [Cited by in F6Publishing: 494] [Article Influence: 53.4] [Reference Citation Analysis]
77 Chatzopoulos K, Aubry M, Gupta S. Immunohistochemical Expression of Carbonic Anhydrase 9 (CA9), Glucose Transporter 1 (GLUT1), and Paired Box 8 (PAX8) in von Hippel Lindau Disease-Related Lesions. Human Pathology 2022. [DOI: 10.1016/j.humpath.2022.02.009] [Reference Citation Analysis]
78 Basar O, Brugge WR. My Treatment Approach: Pancreatic Cysts. Mayo Clin Proc. 2017;92:1519-1531. [PMID: 28890216 DOI: 10.1016/j.mayocp.2017.06.017] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
79 Lawlor RT, Daprà V, Girolami I, Pea A, Pilati C, Nottegar A, Piccoli P, Parolini C, Sperandio N, Capelli P, Scarpa A, Luchini C. CD200 expression is a feature of solid pseudopapillary neoplasms of the pancreas. Virchows Arch 2019;474:105-9. [PMID: 30132130 DOI: 10.1007/s00428-018-2437-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
80 Mafficini A, Lawlor RT, Ghimenton C, Antonello D, Cantù C, Paolino G, Nottegar A, Piredda ML, Salvia R, Milella M, Dei Tos AP, Fassan M, Scarpa A, Luchini C. Solid Pseudopapillary Neoplasm of the Pancreas and Abdominal Desmoid Tumor in a Patient Carrying Two Different BRCA2 Germline Mutations: New Horizons from Tumor Molecular Profiling. Genes (Basel) 2021;12:481. [PMID: 33810291 DOI: 10.3390/genes12040481] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
81 Eiterman A, Lahooti A, Krishna SG. Endosonographic diagnosis of advanced neoplasia in intraductal papillary mucinous neoplasms. World J Gastroenterol 2020; 26(23): 3201-3212 [PMID: 32684735 DOI: 10.3748/wjg.v26.i23.3201] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
82 Ideno N, Yamaguchi H, Ghosh B, Gupta S, Okumura T, Steffen DJ, Fisher CG, Wood LD, Singhi AD, Nakamura M, Gutkind JS, Maitra A. GNASR201C Induces Pancreatic Cystic Neoplasms in Mice That Express Activated KRAS by Inhibiting YAP1 Signaling. Gastroenterology. 2018;155:1593-1607.e12. [PMID: 30142336 DOI: 10.1053/j.gastro.2018.08.006] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 6.8] [Reference Citation Analysis]
83 Kaur A, Lim JYS, Sepramaniam S, Patnaik S, Harmston N, Lee MA, Petretto E, Virshup DM, Madan B. WNT inhibition creates a BRCA-like state in Wnt-addicted cancer. EMBO Mol Med 2021;13:e13349. [PMID: 33660437 DOI: 10.15252/emmm.202013349] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
84 Hickman K, Sadler T, Zhang T, Boninsegna E, Majcher V, Godfrey E. Pancreatic cystic lesions and the role of contrast enhanced endoscopic ultrasound. Clinical Radiology 2022. [DOI: 10.1016/j.crad.2022.02.017] [Reference Citation Analysis]
85 Cowan RW, Maitra A. Genetic progression of pancreatic cancer. Cancer J 2014;20:80-4. [PMID: 24445769 DOI: 10.1097/PPO.0000000000000011] [Cited by in Crossref: 42] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
86 Sinha J, Cao Z, Dai J, Tang H, Partyka K, Hostetter G, Simeone DM, Feng Z, Allen PJ, Brand RE, Haab BB. A Gastric Glycoform of MUC5AC Is a Biomarker of Mucinous Cysts of the Pancreas. PLoS One 2016;11:e0167070. [PMID: 27992432 DOI: 10.1371/journal.pone.0167070] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
87 Zou Y, Huang MZ, Liu FY, Yang BC, Wang LQ, Wang F, Yu XH, Wan L, Wan XD, Xu XY, Li W, Huang OP, He M. Absence of DICER1, CTCF, RPL22, DNMT3A, TRRAP, IDH1 and IDH2 hotspot mutations in patients with various subtypes of ovarian carcinomas. Biomed Rep 2015;3:33-7. [PMID: 25469243 DOI: 10.3892/br.2014.378] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
88 Takeuchi S, Doi M, Ikari N, Yamamoto M, Furukawa T. Mutations in BRCA1, BRCA2, and PALB2, and a panel of 50 cancer-associated genes in pancreatic ductal adenocarcinoma. Sci Rep 2018;8:8105. [PMID: 29802286 DOI: 10.1038/s41598-018-26526-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
89 Tamura K, Ohtsuka T, Date K, Fujimoto T, Matsunaga T, Kimura H, Watanabe Y, Miyazaki T, Ohuchida K, Takahata S, Ishigami K, Oda Y, Mizumoto K, Nakamura M, Tanaka M. Distinction of Invasive Carcinoma Derived From Intraductal Papillary Mucinous Neoplasms From Concomitant Ductal Adenocarcinoma of the Pancreas Using Molecular Biomarkers. Pancreas 2016;45:826-35. [PMID: 26646266 DOI: 10.1097/MPA.0000000000000563] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
90 Jiang X, Cong F. Novel Regulation of Wnt Signaling at the Proximal Membrane Level. Trends Biochem Sci 2016;41:773-83. [PMID: 27377711 DOI: 10.1016/j.tibs.2016.06.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
91 Herranz Pérez R, de la Morena López F, Majano Rodríguez PL, Molina Jiménez F, Vega Piris L, Santander Vaquero C. Molecular analysis of pancreatic cystic neoplasm in routine clinical practice. World J Gastrointest Endosc 2021; 13(2): 56-71 [PMID: 33623640 DOI: 10.4253/wjge.v13.i2.56] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
92 Andersen DK, Andren-Sandberg Å, Duell EJ, Goggins M, Korc M, Petersen GM, Smith JP, Whitcomb DC. Pancreatitis-diabetes-pancreatic cancer: summary of an NIDDK-NCI workshop. Pancreas 2013;42:1227-37. [PMID: 24152948 DOI: 10.1097/MPA.0b013e3182a9ad9d] [Cited by in Crossref: 98] [Cited by in F6Publishing: 54] [Article Influence: 12.3] [Reference Citation Analysis]
93 Petljak M, Alexandrov LB. Understanding mutagenesis through delineation of mutational signatures in human cancer. CARCIN 2016;37:531-40. [DOI: 10.1093/carcin/bgw055] [Cited by in Crossref: 65] [Cited by in F6Publishing: 49] [Article Influence: 10.8] [Reference Citation Analysis]
94 Meißner T, Mark A, Williams C, Berdel WE, Wiebe S, Kerkhoff A, Wardelmann E, Gaiser T, Müller-Tidow C, Rosenstiel P, Arnold N, Leyland-Jones B, Franke A, Stanulla M, Forster M. Metastatic triple-negative breast cancer patient with TP53 tumor mutation experienced 11 months progression-free survival on bortezomib monotherapy without adverse events after ending standard treatments with grade 3 adverse events. Cold Spring Harb Mol Case Stud 2017;3:a001677. [PMID: 28679691 DOI: 10.1101/mcs.a001677] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
95 Basturk O, Hong SM, Wood LD, Adsay NV, Albores-Saavedra J, Biankin AV, Brosens LA, Fukushima N, Goggins M, Hruban RH, Kato Y, Klimstra DS, Klöppel G, Krasinskas A, Longnecker DS, Matthaei H, Offerhaus GJ, Shimizu M, Takaori K, Terris B, Yachida S, Esposito I, Furukawa T; Baltimore Consensus Meeting. A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas. Am J Surg Pathol 2015;39:1730-41. [PMID: 26559377 DOI: 10.1097/PAS.0000000000000533] [Cited by in Crossref: 367] [Cited by in F6Publishing: 159] [Article Influence: 61.2] [Reference Citation Analysis]
96 Frampton AE, Stebbing J, Gall TM, Silver B, Jiao LR, Krell J. Activating mutations of GNAS and KRAS in cystic fluid can help detect intraductal papillary mucinous neoplasms of the pancreas. Expert Rev Mol Diagn. 2015;15:325-328. [PMID: 25656048 DOI: 10.1586/14737159.2015.1002771] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
97 Alexander CM. The Wnt Signaling Landscape of Mammary Stem Cells and Breast Tumors. WNT Signaling in Health and Disease. Elsevier; 2018. pp. 271-98. [DOI: 10.1016/bs.pmbts.2017.11.020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
98 Steel M, Rao S, Ho J, Donnellan F, Yang H, Schaeffer DF. Cytohistological diagnosis of pancreatic serous cystadenoma: a multimodal approach. J Clin Pathol 2019;72:615-21. [DOI: 10.1136/jclinpath-2019-205872] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
99 Bijlsma MF, van Laarhoven HW. The conflicting roles of tumor stroma in pancreatic cancer and their contribution to the failure of clinical trials: a systematic review and critical appraisal. Cancer Metastasis Rev 2015;34:97-114. [PMID: 25566685 DOI: 10.1007/s10555-014-9541-1] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 7.8] [Reference Citation Analysis]
100 Keane MG, Afghani E. A Review of the Diagnosis and Management of Premalignant Pancreatic Cystic Lesions. J Clin Med 2021;10:1284. [PMID: 33808853 DOI: 10.3390/jcm10061284] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
101 Lopez-Serra P, Marcilla M, Villanueva A, Ramos-Fernandez A, Palau A, Leal L, Wahi JE, Setien-Baranda F, Szczesna K, Moutinho C, Martinez-Cardus A, Heyn H, Sandoval J, Puertas S, Vidal A, Sanjuan X, Martinez-Balibrea E, Viñals F, Perales JC, Bramsem JB, Ørntoft TF, Andersen CL, Tabernero J, McDermott U, Boxer MB, Vander Heiden MG, Albar JP, Esteller M. A DERL3-associated defect in the degradation of SLC2A1 mediates the Warburg effect. Nat Commun 2014;5:3608. [PMID: 24699711 DOI: 10.1038/ncomms4608] [Cited by in Crossref: 58] [Cited by in F6Publishing: 58] [Article Influence: 7.3] [Reference Citation Analysis]
102 Voltaggio L, Cimino-Mathews A, Bishop JA, Argani P, Cuda JD, Epstein JI, Hruban RH, Netto GJ, Stoler MH, Taube JM, Vang R, Westra WH, Montgomery EA. Current concepts in the diagnosis and pathobiology of intraepithelial neoplasia: A review by organ system. CA Cancer J Clin 2016;66:408-36. [PMID: 27270763 DOI: 10.3322/caac.21350] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
103 Zarkou V, Galaras A, Giakountis A, Hatzis P. Crosstalk mechanisms between the WNT signaling pathway and long non-coding RNAs. Noncoding RNA Res 2018;3:42-53. [PMID: 30159439 DOI: 10.1016/j.ncrna.2018.04.001] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 7.8] [Reference Citation Analysis]
104 Tamura K, Ohtsuka T, Matsunaga T, Kimura H, Watanabe Y, Ideno N, Aso T, Miyazaki T, Ohuchida K, Takahata S, Ito T, Ushijima Y, Oda Y, Mizumoto K, Tanaka M. Assessment of clonality of multisegmental main duct intraductal papillary mucinous neoplasms of the pancreas based on GNAS mutation analysis. Surgery 2015;157:277-84. [DOI: 10.1016/j.surg.2014.09.013] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
105 Tsukiyama T, Fukui A, Terai S, Fujioka Y, Shinada K, Takahashi H, Yamaguchi TP, Ohba Y, Hatakeyama S. Molecular Role of RNF43 in Canonical and Noncanonical Wnt Signaling. Mol Cell Biol 2015;35:2007-23. [PMID: 25825523 DOI: 10.1128/MCB.00159-15] [Cited by in Crossref: 40] [Cited by in F6Publishing: 27] [Article Influence: 5.7] [Reference Citation Analysis]
106 Efthymiou A, Podas T, Zacharakis E. Endoscopic ultrasound in the diagnosis of pancreatic intraductal papillary mucinous neoplasms. World J Gastroenterol 2014; 20(24): 7785-7793 [PMID: 24976716 DOI: 10.3748/wjg.v20.i24.7785] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
107 Bond CE, McKeone DM, Kalimutho M, Bettington ML, Pearson SA, Dumenil TD, Wockner LF, Burge M, Leggett BA, Whitehall VL. RNF43 and ZNRF3 are commonly altered in serrated pathway colorectal tumorigenesis. Oncotarget 2016;7:70589-600. [PMID: 27661107 DOI: 10.18632/oncotarget.12130] [Cited by in Crossref: 59] [Cited by in F6Publishing: 58] [Article Influence: 14.8] [Reference Citation Analysis]
108 Tatarian T, Winter JM. Genetics of Pancreatic Cancer and Its Implications on Therapy. Surgical Clinics of North America 2016;96:1207-21. [DOI: 10.1016/j.suc.2016.07.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
109 Basturk O, Tan M, Bhanot U, Allen P, Adsay V, Scott SN, Shah R, Berger MF, Askan G, Dikoglu E, Jobanputra V, Wrzeszczynski KO, Sigel C, Iacobuzio-Donahue C, Klimstra DS. The oncocytic subtype is genetically distinct from other pancreatic intraductal papillary mucinous neoplasm subtypes. Mod Pathol 2016;29:1058-69. [PMID: 27282351 DOI: 10.1038/modpathol.2016.98] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 7.2] [Reference Citation Analysis]
110 Fischer CG, Wood LD. From somatic mutation to early detection: insights from molecular characterization of pancreatic cancer precursor lesions. J Pathol 2018;246:395-404. [PMID: 30105857 DOI: 10.1002/path.5154] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 9.0] [Reference Citation Analysis]
111 Nakanuma Y, Kakuda Y, Fukumura Y, Sugino T, Uesaka K, Serizawa M, Terada T, Ohnishi Y. The Pathologic and Genetic Characteristics of the Intestinal Subtype of Intraductal Papillary Neoplasms of the Bile Duct. American Journal of Surgical Pathology 2019;43:1212-20. [DOI: 10.1097/pas.0000000000001295] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
112 Ying H, Dey P, Yao W, Kimmelman AC, Draetta GF, Maitra A, DePinho RA. Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev. 2016;30:355-385. [PMID: 26883357 DOI: 10.1101/gad.275776.115] [Cited by in Crossref: 241] [Cited by in F6Publishing: 226] [Article Influence: 40.2] [Reference Citation Analysis]
113 Cowan RW, Pratt ED, Kang JM, Zhao J, Wilhelm JJ, Abdulla M, Qiao EM, Brennan LP, Ulintz PJ, Bellin MD, Rhim AD. Pancreatic Cancer-Related Mutational Burden Is Not Increased in a Patient Cohort With Clinically Severe Chronic Pancreatitis. Clin Transl Gastroenterol 2021;12:e00431. [PMID: 34797250 DOI: 10.14309/ctg.0000000000000431] [Reference Citation Analysis]
114 Conner JR, Mariño-enríquez A, Mino-kenudson M, Garcia E, Pitman MB, Sholl LM, Srivastava A, Doyle LA. Genomic Characterization of Low- and High-Grade Pancreatic Mucinous Cystic Neoplasms Reveals Recurrent KRAS Alterations in “High-Risk” Lesions. Pancreas 2017;46:665-71. [DOI: 10.1097/mpa.0000000000000805] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 3.2] [Reference Citation Analysis]
115 de Lau W, Peng WC, Gros P, Clevers H. The R-spondin/Lgr5/Rnf43 module: regulator of Wnt signal strength. Genes Dev. 2014;28:305-316. [PMID: 24532711 DOI: 10.1101/gad.235473.113] [Cited by in Crossref: 340] [Cited by in F6Publishing: 314] [Article Influence: 42.5] [Reference Citation Analysis]
116 Zhou Y, Lan J, Wang W, Shi Q, Lan Y, Cheng Z, Guan H. ZNRF3 acts as a tumour suppressor by the Wnt signalling pathway in human gastric adenocarcinoma. J Mol Histol. 2013;44:555-563. [PMID: 23504200 DOI: 10.1007/s10735-013-9504-9] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 3.1] [Reference Citation Analysis]
117 Zhao H, Zhang L, Zhang Y, Zhao L, Wan Q, Wang B, Bu X, Wan M, Shen C. Calmodulin promotes matrix metalloproteinase 9 production and cell migration by inhibiting the ubiquitination and degradation of TBC1D3 oncoprotein in human breast cancer cells. Oncotarget 2017;8:36383-98. [PMID: 28422741 DOI: 10.18632/oncotarget.16756] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
118 Gaujoux S, Chanson P, Bertherat J, Sauvanet A, Ruszniewski P. Hepato-pancreato-biliary lesions are present in both Carney complex and McCune Albright syndrome: comments on P. Salpea and C. Stratakis. Mol Cell Endocrinol. 2014;382:344-345. [PMID: 24161590 DOI: 10.1016/j.mce.2013.10.020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
119 Wu W, Hong X, Li J, Dai M, Wang W, Tong A, Zhu Z, Dai H, Zhao Y. Solid serous cystadenoma of the pancreas: a case report of 2 patients revealing vimentin, β-catenin, α-1 antitrypsin, and α-1 antichymotrypsin as new immunohistochemistry staining markers. Medicine (Baltimore) 2015;94:e644. [PMID: 25816032 DOI: 10.1097/MD.0000000000000644] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
120 Singh P, Kumar P, Rohilla M, Gupta P, Gupta N, Dey P, Srinivasan R, Rajwanshi A, Nada R. Fine needle aspiration cytology with the aid of immunocytochemistry on cell-block confirms the diagnosis of solid pseudopapillary neoplasm of the pancreas. Cytopathology 2021;32:57-64. [PMID: 32319130 DOI: 10.1111/cyt.12838] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
121 Jones M, Zheng Z, Wang J, Dudley J, Albanese E, Kadayifci A, Dias-Santagata D, Le L, Brugge WR, Fernandez-del Castillo C, Mino-Kenudson M, Iafrate AJ, Pitman MB. Impact of next-generation sequencing on the clinical diagnosis of pancreatic cysts. Gastrointest Endosc 2016;83:140-8. [PMID: 26253016 DOI: 10.1016/j.gie.2015.06.047] [Cited by in Crossref: 88] [Cited by in F6Publishing: 71] [Article Influence: 12.6] [Reference Citation Analysis]
122 Rodriguez-Matta E, Hemmerich A, Starr J, Mody K, Severson EA, Colon-Otero G. Molecular genetic changes in solid pseudopapillary neoplasms (SPN) of the pancreas. Acta Oncol 2020;59:1024-7. [PMID: 32672484 DOI: 10.1080/0284186X.2020.1792549] [Reference Citation Analysis]
123 Visani M, Acquaviva G, De Leo A, Sanza V, Merlo L, Maloberti T, Brandes AA, Franceschi E, Di Battista M, Masetti M, Jovine E, Fiorino S, Pession A, Tallini G, de Biase D. Molecular alterations in pancreatic tumors. World J Gastroenterol 2021; 27(21): 2710-2726 [PMID: 34135550 DOI: 10.3748/wjg.v27.i21.2710] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
124 Li Y, Oliver PG, Lu W, Pathak V, Sridharan S, Augelli-Szafran CE, Buchsbaum DJ, Suto MJ. SRI36160 is a specific inhibitor of Wnt/β-catenin signaling in human pancreatic and colorectal cancer cells. Cancer Lett 2017;389:41-8. [PMID: 28043913 DOI: 10.1016/j.canlet.2016.12.030] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
125 Schlitter AM, Segler A, Steiger K, Michalski CW, Jäger C, Konukiewitz B, Pfarr N, Endris V, Bettstetter M, Kong B, Regel I, Kleeff J, Klöppel G, Esposito I. Molecular, morphological and survival analysis of 177 resected pancreatic ductal adenocarcinomas (PDACs): Identification of prognostic subtypes. Sci Rep 2017;7:41064. [PMID: 28145465 DOI: 10.1038/srep41064] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 9.6] [Reference Citation Analysis]
126 Sato H, Liss AS, Mizukami Y. Large-duct pattern invasive adenocarcinoma of the pancreas-a variant mimicking pancreatic cystic neoplasms: A minireview. World J Gastroenterol 2021;27:3262-78. [PMID: 34163110 DOI: 10.3748/wjg.v27.i23.3262] [Reference Citation Analysis]
127 Singhi AD, Wood LD. Early detection of pancreatic cancer using DNA-based molecular approaches. Nat Rev Gastroenterol Hepatol 2021;18:457-68. [PMID: 34099908 DOI: 10.1038/s41575-021-00470-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
128 Tsukiyama T, Zou J, Kim J, Ogamino S, Shino Y, Masuda T, Merenda A, Matsumoto M, Fujioka Y, Hirose T, Terai S, Takahashi H, Ishitani T, Nakayama KI, Ohba Y, Koo BK, Hatakeyama S. A phospho-switch controls RNF43-mediated degradation of Wnt receptors to suppress tumorigenesis. Nat Commun 2020;11:4586. [PMID: 32934222 DOI: 10.1038/s41467-020-18257-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
129 Scarpa A, Real FX, Luchini C. Genetic unrelatedness of co-occurring pancreatic adenocarcinomas and IPMNs challenges current views of clinical management. Gut. 2018;67:1561-1563. [PMID: 29661802 DOI: 10.1136/gutjnl-2018-316151] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
130 Le Gallo M, Lozy F, Bell DW. Next-Generation Sequencing. In: Hedrick Ellenson L, editor. Molecular Genetics of Endometrial Carcinoma. Cham: Springer International Publishing; 2017. pp. 119-48. [DOI: 10.1007/978-3-319-43139-0_5] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 4.7] [Reference Citation Analysis]
131 Chiang AL, Lee LS. Clinical approach to incidental pancreatic cysts. World J Gastroenterol 2016; 22(3): 1236-1245 [PMID: 26811661 DOI: 10.3748/wjg.v22.i3.1236] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 15] [Article Influence: 3.7] [Reference Citation Analysis]
132 Lim J, Allen PJ. The diagnosis and management of intraductal papillary mucinous neoplasms of the pancreas: has progress been made? Updates Surg. 2019;71:209-216. [PMID: 31175628 DOI: 10.1007/s13304-019-00661-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
133 Collet L, Ghurburrun E, Meyers N, Assi M, Pirlot B, Leclercq IA, Couvelard A, Komuta M, Cros J, Demetter P, Lemaigre FP, Borbath I, Jacquemin P. Kras and Lkb1 mutations synergistically induce intraductal papillary mucinous neoplasm derived from pancreatic duct cells. Gut 2020;69:704-14. [PMID: 31154393 DOI: 10.1136/gutjnl-2018-318059] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
134 Liu J, Xiao Q, Xiao J, Niu C, Li Y, Zhang X, Zhou Z, Shu G, Yin G. Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduct Target Ther 2022;7:3. [PMID: 34980884 DOI: 10.1038/s41392-021-00762-6] [Reference Citation Analysis]
135 Giannakis M, Hodis E, Jasmine Mu X, Yamauchi M, Rosenbluh J, Cibulskis K, Saksena G, Lawrence MS, Qian ZR, Nishihara R, Van Allen EM, Hahn WC, Gabriel SB, Lander ES, Getz G, Ogino S, Fuchs CS, Garraway LA. RNF43 is frequently mutated in colorectal and endometrial cancers. Nat Genet. 2014;46:1264-1266. [PMID: 25344691 DOI: 10.1038/ng.3127] [Cited by in Crossref: 268] [Cited by in F6Publishing: 252] [Article Influence: 33.5] [Reference Citation Analysis]
136 Bai G, Wu C, Gao Y, Shu G. Exploring the Functional Disorder and Corresponding Key Transcription Factors in Intraductal Papillary Mucinous Neoplasms Progression. Int J Genomics 2015;2015:197603. [PMID: 26425543 DOI: 10.1155/2015/197603] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
137 Gala MK, Mizukami Y, Le LP, Moriichi K, Austin T, Yamamoto M, Lauwers GY, Bardeesy N, Chung DC. Germline mutations in oncogene-induced senescence pathways are associated with multiple sessile serrated adenomas. Gastroenterology 2014;146:520-9. [PMID: 24512911 DOI: 10.1053/j.gastro.2013.10.045] [Cited by in Crossref: 72] [Cited by in F6Publishing: 68] [Article Influence: 9.0] [Reference Citation Analysis]
138 Kadera BE, Toste PA, Wu N, Li L, Nguyen AH, Dawson DW, Donahue TR. Low expression of the E3 ubiquitin ligase CBL confers chemoresistance in human pancreatic cancer and is targeted by epidermal growth factor receptor inhibition. Clin Cancer Res. 2015;21:157-165. [PMID: 25348515 DOI: 10.1158/1078-0432.ccr-14-0610] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
139 An S, Kim MJ, Kim SJ, Sung YN, Kim YW, Song KB, Hwang DW, Kim SC, Hruban RH, Hong SM. Multiple KRAS mutations in the non-mucinous epithelial lining in the majority of mucinous cystic neoplasms of the pancreas. Histopathology 2019;75:559-67. [PMID: 31077597 DOI: 10.1111/his.13897] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
140 Vincent A, Hong SM, Hu C, Omura N, Young A, Kim H, Yu J, Knight S, Ayars M, Griffith M, Van Seuningen I, Maitra A, Goggins M. Epigenetic silencing of EYA2 in pancreatic adenocarcinomas promotes tumor growth. Oncotarget 2014;5:2575-87. [PMID: 24810906 DOI: 10.18632/oncotarget.1842] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
141 Reid MD, Centeno BA. Ancillary Studies, Including Immunohistochemistry and Molecular Studies, in Pancreatic Cytology. Surg Pathol Clin 2014;7:1-34. [PMID: 26839266 DOI: 10.1016/j.path.2013.11.001] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
142 Alexandrov LB, Stratton MR. Mutational signatures: the patterns of somatic mutations hidden in cancer genomes. Curr Opin Genet Dev. 2014;24:52-60. [PMID: 24657537 DOI: 10.1016/j.gde.2013.11.014] [Cited by in Crossref: 289] [Cited by in F6Publishing: 237] [Article Influence: 32.1] [Reference Citation Analysis]
143 Valero V 3rd, Saunders TJ, He J, Weiss MJ, Cameron JL, Dholakia A, Wild AT, Shin EJ, Khashab MA, O'Broin-Lennon AM, Ali SZ, Laheru D, Hruban RH, Iacobuzio-Donahue CA, Herman JM, Wolfgang CL. Reliable Detection of Somatic Mutations in Fine Needle Aspirates of Pancreatic Cancer With Next-generation Sequencing: Implications for Surgical Management. Ann Surg 2016;263:153-61. [PMID: 26020105 DOI: 10.1097/SLA.0000000000001156] [Cited by in Crossref: 32] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
144 Springer S, Wang Y, Dal Molin M, Masica DL, Jiao Y, Kinde I, Blackford A, Raman SP, Wolfgang CL, Tomita T, Niknafs N, Douville C, Ptak J, Dobbyn L, Allen PJ, Klimstra DS, Schattner MA, Schmidt CM, Yip-Schneider M, Cummings OW, Brand RE, Zeh HJ, Singhi AD, Scarpa A, Salvia R, Malleo G, Zamboni G, Falconi M, Jang JY, Kim SW, Kwon W, Hong SM, Song KB, Kim SC, Swan N, Murphy J, Geoghegan J, Brugge W, Fernandez-Del Castillo C, Mino-Kenudson M, Schulick R, Edil BH, Adsay V, Paulino J, van Hooft J, Yachida S, Nara S, Hiraoka N, Yamao K, Hijioka S, van der Merwe S, Goggins M, Canto MI, Ahuja N, Hirose K, Makary M, Weiss MJ, Cameron J, Pittman M, Eshleman JR, Diaz LA Jr, Papadopoulos N, Kinzler KW, Karchin R, Hruban RH, Vogelstein B, Lennon AM. A combination of molecular markers and clinical features improve the classification of pancreatic cysts. Gastroenterology. 2015;149:1501-1510. [PMID: 26253305 DOI: 10.1053/j.gastro.2015.07.041] [Cited by in Crossref: 258] [Cited by in F6Publishing: 211] [Article Influence: 36.9] [Reference Citation Analysis]
145 Liu R, Shi P, Wang Z, Yuan C, Cui H. Molecular Mechanisms of MYCN Dysregulation in Cancers. Front Oncol 2020;10:625332. [PMID: 33614505 DOI: 10.3389/fonc.2020.625332] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
146 Takano S, Fukasawa M, Maekawa S, Kadokura M, Miura M, Shindo H, Takahashi E, Sato T, Enomoto N. Deep sequencing of cancer-related genes revealed GNAS mutations to be associated with intraductal papillary mucinous neoplasms and its main pancreatic duct dilation. PLoS One 2014;9:e98718. [PMID: 24897499 DOI: 10.1371/journal.pone.0098718] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
147 Sawai H, Kurimoto M, Koide S, Kiriyama Y, Haba S, Matsuo Y, Morimoto M, Koide H, Kamiya A, Yamao K. Invasive Ductal Carcinoma Arising in Mucinous Cystic Neoplasm of Pancreas: A Case Report. Am J Case Rep 2019;20:242-7. [PMID: 30798329 DOI: 10.12659/AJCR.914092] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
148 Fabbri C, Gibiino G, Fornelli A, Cennamo V, Grifoni D, Visani M, Acquaviva G, Fassan M, Fiorino S, Giovanelli S, Bassi M, Ghersi S, Tallini G, Jovine E, Gasbarrini A, de Biase D. Team work and cytopathology molecular diagnosis of solid pancreatic lesions. Dig Endosc. 2017;29:657-666. [PMID: 28190274 DOI: 10.1111/den.12845] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
149 Molin MD, Wood LD. Very long-term survival in pancreatic cancer. Aging (Albany NY) 2015;7:360-1. [PMID: 26143583 DOI: 10.18632/aging.100771] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
150 Cancer Genome Atlas Research Network. Cancer Genome Atlas Research Network. Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell. 2017;32:185-203.e13. [PMID: 28810144 DOI: 10.1016/j.ccell.2017.07.007] [Cited by in Crossref: 700] [Cited by in F6Publishing: 595] [Article Influence: 140.0] [Reference Citation Analysis]
151 Fearon ER, Spence JR. Cancer biology: a new RING to Wnt signaling. Curr Biol 2012;22:R849-51. [PMID: 23058807 DOI: 10.1016/j.cub.2012.08.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
152 Gabitova-Cornell L, Surumbayeva A, Peri S, Franco-Barraza J, Restifo D, Weitz N, Ogier C, Goldman AR, Hartman TR, Francescone R, Tan Y, Nicolas E, Shah N, Handorf EA, Cai KQ, O'Reilly AM, Sloma I, Chiaverelli R, Moffitt RA, Khazak V, Fang CY, Golemis EA, Cukierman E, Astsaturov I. Cholesterol Pathway Inhibition Induces TGF-β Signaling to Promote Basal Differentiation in Pancreatic Cancer. Cancer Cell 2020;38:567-583.e11. [PMID: 32976774 DOI: 10.1016/j.ccell.2020.08.015] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
153 Sausen M, Leary RJ, Jones S, Wu J, Reynolds CP, Liu X, Blackford A, Parmigiani G, Diaz LA, Papadopoulos N. Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma. Nat Genet. 2013;45:12-17. [PMID: 23202128 DOI: 10.1038/ng.2493] [Cited by in Crossref: 282] [Cited by in F6Publishing: 258] [Article Influence: 28.2] [Reference Citation Analysis]
154 Norris AL, Roberts NJ, Jones S, Wheelan SJ, Papadopoulos N, Vogelstein B, Kinzler KW, Hruban RH, Klein AP, Eshleman JR. Familial and sporadic pancreatic cancer share the same molecular pathogenesis. Fam Cancer. 2015;14:95-103. [PMID: 25240578 DOI: 10.1007/s10689-014-9755-y] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 5.4] [Reference Citation Analysis]
155 Matthaei H, Wu J, Dal Molin M, Shi C, Perner S, Kristiansen G, Lingohr P, Kalff JC, Wolfgang CL, Kinzler KW, Vogelstein B, Maitra A, Hruban RH. GNAS sequencing identifies IPMN-specific mutations in a subgroup of diminutive pancreatic cysts referred to as "incipient IPMNs". Am J Surg Pathol 2014;38:360-3. [PMID: 24525507 DOI: 10.1097/PAS.0000000000000117] [Cited by in Crossref: 37] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
156 Agaimy A, Mueller SK, Bumm K, Iro H, Moskalev EA, Hartmann A, Stoehr R, Haller F. Intraductal Papillary Mucinous Neoplasms of Minor Salivary Glands With AKT1 p.Glu17Lys Mutation. American Journal of Surgical Pathology 2018;42:1076-82. [DOI: 10.1097/pas.0000000000001080] [Cited by in Crossref: 16] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
157 Hijikata Y, Okazaki T, Tanaka Y, Murahashi M, Yamada Y, Yamada K, Takahashi A, Inoue H, Kishimoto J, Nakanishi Y, Oda Y, Nakamura Y, Tani K. A phase I clinical trial of RNF43 peptide-related immune cell therapy combined with low-dose cyclophosphamide in patients with advanced solid tumors. PLoS One 2018;13:e0187878. [PMID: 29293510 DOI: 10.1371/journal.pone.0187878] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
158 Wang B, Zhao H, Zhao L, Zhang Y, Wan Q, Shen Y, Bu X, Wan M, Shen C. Up-regulation of OLR1 expression by TBC1D3 through activation of TNFα/NF-κB pathway promotes the migration of human breast cancer cells. Cancer Lett 2017;408:60-70. [PMID: 28844714 DOI: 10.1016/j.canlet.2017.08.021] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
159 Van Treeck BJ, Lotfalla M, Czeczok TW, Mounajjed T, Moreira RK, Allende DS, Reid MD, Naini BV, Westerhoff M, Adsay NV, Kerr SE, Rizvi SH, Smoot RL, Liu Y, Davila J, Graham RP. Molecular and Immunohistochemical Analysis of Mucinous Cystic Neoplasm of the Liver. Am J Clin Pathol 2020;154:837-47. [PMID: 32880620 DOI: 10.1093/ajcp/aqaa115] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
160 Nakazato T, Suzuki Y, Tanaka R, Abe N, Masaki T, Mori T, Ohkura Y, Sugiyama M. Effect of Reprimo Down-regulation on Malignant Transformation of Intraductal Papillary Mucinous Neoplasm. Pancreas 2018;47:291-5. [PMID: 29401170 DOI: 10.1097/MPA.0000000000001002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
161 Lennon AM, Wolfgang CL, Canto MI, Klein AP, Herman JM, Goggins M, Fishman EK, Kamel I, Weiss MJ, Diaz LA, Papadopoulos N, Kinzler KW, Vogelstein B, Hruban RH. The Early Detection of Pancreatic Cancer: What Will It Take to Diagnose and Treat Curable Pancreatic Neoplasia? Cancer Res 2014;74:3381-9. [DOI: 10.1158/0008-5472.can-14-0734] [Cited by in Crossref: 144] [Cited by in F6Publishing: 80] [Article Influence: 18.0] [Reference Citation Analysis]
162 Matthaei H, Feldmann G, Lingohr P, Kalff JC. Molecular diagnostics of pancreatic cysts. Langenbecks Arch Surg 2013;398:1021-7. [DOI: 10.1007/s00423-013-1116-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
163 Zhang Y, Liu Q, Wei W, Zhang G, Yan S, Dai R, Sun Y, Su D, Lv S, Xia Y, Li J, Li C. Bortezomib potentiates antitumor activity of mitoxantrone through dampening Wnt/β-catenin signal pathway in prostate cancer cells. BMC Cancer 2021;21:1101. [PMID: 34645397 DOI: 10.1186/s12885-021-08841-1] [Reference Citation Analysis]
164 Cao Z, Maupin K, Curnutte B, Fallon B, Feasley CL, Brouhard E, Kwon R, West CM, Cunningham J, Brand R, Castelli P, Crippa S, Feng Z, Allen P, Simeone DM, Haab BB. Specific glycoforms of MUC5AC and endorepellin accurately distinguish mucinous from nonmucinous pancreatic cysts. Mol Cell Proteomics 2013;12:2724-34. [PMID: 23836919 DOI: 10.1074/mcp.M113.030700] [Cited by in Crossref: 27] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
165 Theisen BK, Wald AI, Singhi AD. Molecular Diagnostics in the Evaluation of Pancreatic Cysts. Surg Pathol Clin. 2016;9:441-456. [PMID: 27523971 DOI: 10.1016/j.path.2016.04.008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 3.4] [Reference Citation Analysis]
166 Sadot E, Basturk O, Klimstra DS, Gönen M, Lokshin A, Do RK, D'Angelica MI, DeMatteo RP, Kingham TP, Jarnagin WR, Allen PJ. Tumor-associated Neutrophils and Malignant Progression in Intraductal Papillary Mucinous Neoplasms: An Opportunity for Identification of High-risk Disease. Ann Surg 2015;262:1102-7. [PMID: 25563865 DOI: 10.1097/SLA.0000000000001044] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
167 Kosmidis C, Sapalidis K, Kotidis E, Mixalopoulos N, Zarogoulidis P, Tsavlis D, Baka S, Man YG, Kanellos J. Pancreatic cancer from bench to bedside: molecular pathways and treatment options. Ann Transl Med 2016;4:165. [PMID: 27275478 DOI: 10.21037/atm.2016.05.11] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
168 Wang D, Tan J, Xu Y, Han M, Tu Y, Zhu Z, Dou C, Xin J, Tan X, Zeng JP, Zhao G, Liu Z. The ubiquitin ligase RNF43 downregulation increases membrane expression of frizzled receptor in pancreatic ductal adenocarcinoma. Tumour Biol 2016;37:627-31. [PMID: 26240024 DOI: 10.1007/s13277-015-3499-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
169 Ren B, Liu X, Suriawinata AA. Pancreatic Ductal Adenocarcinoma and Its Precursor Lesions: Histopathology, Cytopathology, and Molecular Pathology. Am J Pathol. 2019;189:9-21. [PMID: 30558727 DOI: 10.1016/j.ajpath.2018.10.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
170 Jiang X, Hao HX, Growney JD, Woolfenden S, Bottiglio C, Ng N, Lu B, Hsieh MH, Bagdasarian L, Meyer R. Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma. Proc Natl Acad Sci USA. 2013;110:12649-12654. [PMID: 23847203 DOI: 10.1073/pnas.1307218110] [Cited by in Crossref: 232] [Cited by in F6Publishing: 220] [Article Influence: 25.8] [Reference Citation Analysis]
171 Goldsberry WN, Londoño A, Randall TD, Norian LA, Arend RC. A Review of the Role of Wnt in Cancer Immunomodulation. Cancers (Basel) 2019;11:E771. [PMID: 31167446 DOI: 10.3390/cancers11060771] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 9.0] [Reference Citation Analysis]
172 Amato E, Molin MD, Mafficini A, Yu J, Malleo G, Rusev B, Fassan M, Antonello D, Sadakari Y, Castelli P, Zamboni G, Maitra A, Salvia R, Hruban RH, Bassi C, Capelli P, Lawlor RT, Goggins M, Scarpa A. Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas. J Pathol. 2014;233:217-227. [PMID: 24604757 DOI: 10.1002/path.4344] [Cited by in Crossref: 218] [Cited by in F6Publishing: 181] [Article Influence: 27.3] [Reference Citation Analysis]
173 Elias KM, Tsantoulis P, Tille JC, Vitonis A, Doyle LA, Hornick JL, Kaya G, Barnes L, Cramer DW, Puppa G, Stuckelberger S, Hooda J, Dietrich PY, Goggins M, Kerr CL, Birrer M, Hirsch MS, Drapkin R, Labidi-Galy SI. Primordial germ cells as a potential shared cell of origin for mucinous cystic neoplasms of the pancreas and mucinous ovarian tumors. J Pathol. 2018;246:459-469. [PMID: 30229909 DOI: 10.1002/path.5161] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
174 Chen JJ, Fan Y, Boehning D. Regulation of Dynamic Protein S-Acylation. Front Mol Biosci 2021;8:656440. [PMID: 33981723 DOI: 10.3389/fmolb.2021.656440] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
175 Wang Z, Zhao T, Zhang S, Wang J, Chen Y, Zhao H, Yang Y, Shi S, Chen Q, Liu K. The Wnt signaling pathway in tumorigenesis, pharmacological targets, and drug development for cancer therapy. Biomark Res 2021;9:68. [PMID: 34488905 DOI: 10.1186/s40364-021-00323-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
176 Patra KC, Bardeesy N, Mizukami Y. Diversity of Precursor Lesions For Pancreatic Cancer: The Genetics and Biology of Intraductal Papillary Mucinous Neoplasm. Clin Transl Gastroenterol. 2017;8:e86. [PMID: 28383565 DOI: 10.1038/ctg.2017.3] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 10.2] [Reference Citation Analysis]
177 Hruban RH. Is the Early Detection of Pancreatic Cancer Possible? It Is Good News, Bad News. Pancreas 2019;48:591-3. [PMID: 31090658 DOI: 10.1097/MPA.0000000000001299] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
178 Hosoda W, Wood LD. Molecular Genetics of Pancreatic Neoplasms. Surg Pathol Clin 2016;9:685-703. [PMID: 27926367 DOI: 10.1016/j.path.2016.05.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
179 Wood LD. Pancreatic cancer genomes: toward molecular subtyping and novel approaches to diagnosis and therapy. Mol Diagn Ther 2013;17:287-97. [PMID: 23757204 DOI: 10.1007/s40291-013-0043-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
180 Yu J, Sadakari Y, Shindo K, Suenaga M, Brant A, Almario JAN, Borges M, Barkley T, Fesharakizadeh S, Ford M, Hruban RH, Shin EJ, Lennon AM, Canto MI, Goggins M. Digital next-generation sequencing identifies low-abundance mutations in pancreatic juice samples collected from the duodenum of patients with pancreatic cancer and intraductal papillary mucinous neoplasms. Gut. 2017;66:1677-1687. [PMID: 27432539 DOI: 10.1136/gutjnl-2015-311166] [Cited by in Crossref: 88] [Cited by in F6Publishing: 80] [Article Influence: 14.7] [Reference Citation Analysis]
181 Zebisch M, Xu Y, Krastev C, MacDonald BT, Chen M, Gilbert RJ, He X, Jones EY. Structural and molecular basis of ZNRF3/RNF43 transmembrane ubiquitin ligase inhibition by the Wnt agonist R-spondin. Nat Commun 2013;4:2787. [PMID: 24225776 DOI: 10.1038/ncomms3787] [Cited by in Crossref: 92] [Cited by in F6Publishing: 87] [Article Influence: 11.5] [Reference Citation Analysis]
182 Takahashi N, Yamaguchi K, Ikenoue T, Fujii T, Furukawa Y. Identification of two Wnt-responsive elements in the intron of RING finger protein 43 (RNF43) gene. PLoS One 2014;9:e86582. [PMID: 24466159 DOI: 10.1371/journal.pone.0086582] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
183 Komatsu H, Tanji E, Sakata N, Aoki T, Motoi F, Naitoh T, Katayose Y, Egawa S, Unno M, Furukawa T. A GNAS mutation found in pancreatic intraductal papillary mucinous neoplasms induces drastic alterations of gene expression profiles with upregulation of mucin genes. PLoS One. 2014;9:e87875. [PMID: 24498386 DOI: 10.1371/journal.pone.0087875] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 4.6] [Reference Citation Analysis]
184 Maker AV, Carrara S, Jamieson NB, Pelaez-Luna M, Lennon AM, Dal Molin M, Scarpa A, Frulloni L, Brugge WR. Cyst fluid biomarkers for intraductal papillary mucinous neoplasms of the pancreas: a critical review from the international expert meeting on pancreatic branch-duct-intraductal papillary mucinous neoplasms. J Am Coll Surg 2015;220:243-53. [PMID: 25592469 DOI: 10.1016/j.jamcollsurg.2014.11.001] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 4.9] [Reference Citation Analysis]
185 Zhang L, Bluth MH, Bhalla A. Molecular Diagnostics in the Neoplasms of the Pancreas, Liver, Gallbladder, and Extrahepatic Biliary Tract: 2018 Update. Clin Lab Med 2018;38:367-84. [PMID: 29776636 DOI: 10.1016/j.cll.2018.03.003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
186 Jun SY, Hong SM. Nonductal Pancreatic Cancers. Surg Pathol Clin. 2016;9:581-593. [PMID: 27926361 DOI: 10.1016/j.path.2016.05.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
187 Tu J, Park S, Yu W, Zhang S, Wu L, Carmon K, Liu QJ. The most common RNF43 mutant G659Vfs*41 is fully functional in inhibiting Wnt signaling and unlikely to play a role in tumorigenesis. Sci Rep 2019;9:18557. [PMID: 31811196 DOI: 10.1038/s41598-019-54931-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
188 Jiang X, Cong F. Probing Wnt Receptor Turnover: A Critical Regulatory Point of Wnt Pathway. Methods Mol Biol 2016;1481:39-48. [PMID: 27590150 DOI: 10.1007/978-1-4939-6393-5_5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
189 Ishizu S, Setoyama T, Ueo T, Ueda Y, Kodama Y, Ida H, Kawaguchi Y, Yoshizawa A, Chiba T, Miyamoto S. Concomitant Case of Intraductal Papillary Mucinous Neoplasm of the Pancreas and Functioning Pancreatic Neuroendocrine Tumor (Vasoactive Intestinal Polypeptide-Producing Tumor): First Report. Pancreas 2016;45:e24-5. [PMID: 27295534 DOI: 10.1097/MPA.0000000000000578] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
190 Reuss DE, Piro RM, Jones DTW, Simon M, Ketter R, Kool M, Becker A, Sahm F, Pusch S, Meyer J, Hagenlocher C, Schweizer L, Capper D, Kickingereder P, Mucha J, Koelsche C, Jäger N, Santarius T, Tarpey PS, Stephens PJ, Andrew Futreal P, Wellenreuther R, Kraus J, Lenartz D, Herold-mende C, Hartmann C, Mawrin C, Giese N, Eils R, Collins VP, König R, Wiestler OD, Pfister SM, von Deimling A. Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations. Acta Neuropathol 2013;125:351-8. [DOI: 10.1007/s00401-013-1093-x] [Cited by in Crossref: 145] [Cited by in F6Publishing: 127] [Article Influence: 16.1] [Reference Citation Analysis]
191 Park J, Han D, Do M, Woo J, Wang JI, Han Y, Kwon W, Kim SW, Jang JY, Kim Y. Proteome characterization of human pancreatic cyst fluid from intraductal papillary mucinous neoplasm by liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 2017;31:1761-72. [PMID: 28815810 DOI: 10.1002/rcm.7959] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
192 Husain K, Centeno BA, Chen DT, Fulp WJ, Perez M, Zhang Lee G, Luetteke N, Hingorani SR, Sebti SM, Malafa MP. Prolonged survival and delayed progression of pancreatic intraepithelial neoplasia in LSL-KrasG12D/+;Pdx-1-Cre mice by vitamin E δ-tocotrienol. Carcinogenesis 2013;34:858-63. [PMID: 23302291 DOI: 10.1093/carcin/bgt002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
193 Lennon AM, Manos LL, Hruban RH, Ali SZ, Fishman EK, Kamel IR, Raman SP, Zaheer A, Hutfless S, Salamone A, Kiswani V, Ahuja N, Makary MA, Weiss MJ, Hirose K, Goggins M, Wolfgang CL. Role of a multidisciplinary clinic in the management of patients with pancreatic cysts: a single-center cohort study. Ann Surg Oncol 2014;21:3668-74. [PMID: 24806116 DOI: 10.1245/s10434-014-3739-x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 22] [Article Influence: 4.5] [Reference Citation Analysis]
194 Chiblak S, Steinbauer B, Pohl-Arnold A, Kucher D, Abdollahi A, Schwager C, Höft B, Esposito I, Müller-Decker K. K-Ras and cyclooxygenase-2 coactivation augments intraductal papillary mucinous neoplasm and Notch1 mimicking human pancreas lesions. Sci Rep 2016;6:29455. [PMID: 27381829 DOI: 10.1038/srep29455] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
195 Ideno N, Ohtsuka T, Matsunaga T, Kimura H, Watanabe Y, Tamura K, Aso T, Aishima S, Miyasaka Y, Ohuchida K, Ueda J, Takahata S, Oda Y, Mizumoto K, Tanaka M. Clinical significance of GNAS mutation in intraductal papillary mucinous neoplasm of the pancreas with concomitant pancreatic ductal adenocarcinoma. Pancreas 2015;44:311-20. [PMID: 25479586 DOI: 10.1097/MPA.0000000000000258] [Cited by in Crossref: 35] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
196 Layfield LJ, Ehya H, Filie AC, Hruban RH, Jhala N, Joseph L, Vielh P, Pitman MB;  Papanicolaou Society of Cytopathology. Utilization of ancillary studies in the cytologic diagnosis of biliary and pancreatic lesions: the Papanicolaou Society of Cytopathology guidelines for pancreatobiliary cytology. Diagn Cytopathol. 2014;42:351-362. [PMID: 24639398 DOI: 10.1002/dc.23093] [Cited by in Crossref: 53] [Cited by in F6Publishing: 43] [Article Influence: 6.6] [Reference Citation Analysis]
197 Wood LD, Noë M, Hackeng W, Brosens LA, Bhaijee F, Debeljak M, Yu J, Suenaga M, Singhi AD, Zaheer A, Boyce A, Robinson C, Eshleman JR, Goggins MG, Hruban RH, Collins MT, Lennon AM, Montgomery EA. Patients with McCune-Albright syndrome have a broad spectrum of abnormalities in the gastrointestinal tract and pancreas. Virchows Arch 2017;470:391-400. [PMID: 28188442 DOI: 10.1007/s00428-017-2086-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
198 Noë M, Niknafs N, Fischer CG, Hackeng WM, Beleva Guthrie V, Hosoda W, Debeljak M, Papp E, Adleff V, White JR, Luchini C, Pea A, Scarpa A, Butturini G, Zamboni G, Castelli P, Hong SM, Yachida S, Hiraoka N, Gill AJ, Samra JS, Offerhaus GJA, Hoorens A, Verheij J, Jansen C, Adsay NV, Jiang W, Winter J, Albores-Saavedra J, Terris B, Thompson ED, Roberts NJ, Hruban RH, Karchin R, Scharpf RB, Brosens LAA, Velculescu VE, Wood LD. Genomic characterization of malignant progression in neoplastic pancreatic cysts. Nat Commun 2020;11:4085. [PMID: 32796935 DOI: 10.1038/s41467-020-17917-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
199 Fenderico N, van Scherpenzeel RC, Goldflam M, Proverbio D, Jordens I, Kralj T, Stryeck S, Bass TZ, Hermans G, Ullman C, Aastrup T, Gros P, Maurice MM. Anti-LRP5/6 VHHs promote differentiation of Wnt-hypersensitive intestinal stem cells. Nat Commun 2019;10:365. [PMID: 30664649 DOI: 10.1038/s41467-018-08172-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
200 Pedone E, Marucci L. Role of β-Catenin Activation Levels and Fluctuations in Controlling Cell Fate. Genes (Basel) 2019;10:E176. [PMID: 30823613 DOI: 10.3390/genes10020176] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
201 Wood LD, Klimstra DS. Pathology and genetics of pancreatic neoplasms with acinar differentiation. Semin Diagn Pathol. 2014;31:491-497. [PMID: 25441307 DOI: 10.1053/j.semdp.2014.08.003] [Cited by in Crossref: 39] [Cited by in F6Publishing: 29] [Article Influence: 4.9] [Reference Citation Analysis]
202 Dal Molin M, Zhang M, de Wilde RF, Ottenhof NA, Rezaee N, Wolfgang CL, Blackford A, Vogelstein B, Kinzler KW, Papadopoulos N, Hruban RH, Maitra A, Wood LD. Very Long-term Survival Following Resection for Pancreatic Cancer Is Not Explained by Commonly Mutated Genes: Results of Whole-Exome Sequencing Analysis. Clin Cancer Res 2015;21:1944-50. [PMID: 25623214 DOI: 10.1158/1078-0432.CCR-14-2600] [Cited by in Crossref: 52] [Cited by in F6Publishing: 28] [Article Influence: 7.4] [Reference Citation Analysis]
203 Nusse R, Clevers H. Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities. Cell 2017;169:985-99. [PMID: 28575679 DOI: 10.1016/j.cell.2017.05.016] [Cited by in Crossref: 1477] [Cited by in F6Publishing: 1430] [Article Influence: 295.4] [Reference Citation Analysis]
204 Kwon RS. Advances in the diagnosis of cystic neoplasms of the pancreas. Curr Opin Gastroenterol 2012;28:494-500. [PMID: 22782021 DOI: 10.1097/MOG.0b013e3283567f3f] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
205 Jiao Y, Yonescu R, Offerhaus GJ, Klimstra DS, Maitra A, Eshleman JR, Herman JG, Poh W, Pelosof L, Wolfgang CL, Vogelstein B, Kinzler KW, Hruban RH, Papadopoulos N, Wood LD. Whole-exome sequencing of pancreatic neoplasms with acinar differentiation. J Pathol. 2014;232:428-435. [PMID: 24293293 DOI: 10.1002/path.4310] [Cited by in Crossref: 107] [Cited by in F6Publishing: 83] [Article Influence: 13.4] [Reference Citation Analysis]
206 Robinson C, Estrada A, Zaheer A, Singh VK, Wolfgang CL, Goggins MG, Hruban RH, Wood LD, Noë M, Montgomery EA, Guthrie LC, Lennon AM, Boyce AM, Collins MT. Clinical and Radiographic Gastrointestinal Abnormalities in McCune-Albright Syndrome.J Clin Endocrinol Metab. 2018;103:4293-4303. [PMID: 30124968 DOI: 10.1210/jc.2018-01022] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
207 Fassan M, Rusev B, Corbo V, Gasparini P, Luchini C, Vicentini C, Mafficini A, Paiella S, Salvia R, Cataldo I, Scarpa A, Huebner K. Fhit down-regulation is an early event in pancreatic carcinogenesis. Virchows Arch 2017;470:647-53. [PMID: 28289900 DOI: 10.1007/s00428-017-2105-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
208 Wang J, Rattner A, Nathans J. A transcriptome atlas of the mouse iris at single-cell resolution defines cell types and the genomic response to pupil dilation. Elife 2021;10:e73477. [PMID: 34783308 DOI: 10.7554/eLife.73477] [Reference Citation Analysis]
209 Kuboki Y, Shimizu K, Hatori T, Yamamoto M, Shibata N, Shiratori K, Furukawa T. Molecular biomarkers for progression of intraductal papillary mucinous neoplasm of the pancreas. Pancreas. 2015;44:227-235. [PMID: 25423558 DOI: 10.1097/mpa.0000000000000253] [Cited by in Crossref: 48] [Cited by in F6Publishing: 22] [Article Influence: 6.9] [Reference Citation Analysis]
210 Matthaei H, Wu J, Dal Molin M, Debeljak M, Lingohr P, Katabi N, Klimstra DS, Adsay NV, Eshleman JR, Schulick RD, Kinzler KW, Vogelstein B, Hruban RH, Maitra A. GNAS codon 201 mutations are uncommon in intraductal papillary neoplasms of the bile duct. HPB (Oxford) 2012;14:677-83. [PMID: 22954004 DOI: 10.1111/j.1477-2574.2012.00504.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
211 Vikkath N, Valiyaveedan S, Nampoothiri S, Radhakrishnan N, Pillai GS, Nair V, Pooleri GK, Mathew G, Menon KN, Ariyannur PS, Pillai AB. Genotype–phenotype analysis of von Hippel–Lindau syndrome in fifteen Indian families. Familial Cancer 2015;14:585-94. [DOI: 10.1007/s10689-015-9806-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
212 Yu N, Zhu H, Tao Y, Huang Y, Song X, Zhou Y, Li Y, Pei Q, Tan Q, Pei H. Association between prognostic survival of human colorectal carcinoma and ZNRF3 expression. Onco Targets Ther 2016;9:6679-87. [PMID: 27822070 DOI: 10.2147/OTT.S108134] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
213 Imaoka H, Sasaki M, Hashimoto Y, Watanabe K, Ikeda M. New Era of Endoscopic Ultrasound-Guided Tissue Acquisition: Next-Generation Sequencing by Endoscopic Ultrasound-Guided Sampling for Pancreatic Cancer. J Clin Med 2019;8:E1173. [PMID: 31387310 DOI: 10.3390/jcm8081173] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
214 Walsh RM, Perlmutter BC, Adsay V, Reid MD, Baker ME, Stevens T, Hue JJ, Hardacre JM, Shen GQ, Simon R, Aleassa EM, Augustin T, Eckhoff A, Allen PJ, Goh BKP. Advances in the management of pancreatic cystic neoplasms. Curr Probl Surg 2021;58:100879. [PMID: 34144739 DOI: 10.1016/j.cpsurg.2020.100879] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
215 Madan B, Ke Z, Harmston N, Ho SY, Frois AO, Alam J, Jeyaraj DA, Pendharkar V, Ghosh K, Virshup IH, Manoharan V, Ong EH, Sangthongpitag K, Hill J, Petretto E, Keller TH, Lee MA, Matter A, Virshup DM. Wnt addiction of genetically defined cancers reversed by PORCN inhibition. Oncogene. 2016;35:2197-2207. [PMID: 26257057 DOI: 10.1038/onc.2015.280] [Cited by in Crossref: 167] [Cited by in F6Publishing: 158] [Article Influence: 23.9] [Reference Citation Analysis]
216 Arpalahti L, Haglund C, Holmberg CI. Proteostasis Dysregulation in Pancreatic Cancer. Adv Exp Med Biol 2020;1233:101-15. [PMID: 32274754 DOI: 10.1007/978-3-030-38266-7_4] [Reference Citation Analysis]
217 Basturk O, Askan G. Benign Tumors and Tumorlike Lesions of the Pancreas. Surg Pathol Clin 2016;9:619-41. [PMID: 27926363 DOI: 10.1016/j.path.2016.05.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
218 Aguirre AJ, Collisson EA. Advances in the Genetics and Biology of Pancreatic Cancer. Cancer J 2017;23:315-20. [PMID: 29189326 DOI: 10.1097/PPO.0000000000000286] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
219 Hayashi A, Hong J, Iacobuzio-Donahue CA. The pancreatic cancer genome revisited. Nat Rev Gastroenterol Hepatol 2021;18:469-81. [PMID: 34089011 DOI: 10.1038/s41575-021-00463-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
220 Herman JM. Pancreaticobiliary malignancies: past, present, and future. Semin Radiat Oncol 2014;24:61-6. [PMID: 24635862 DOI: 10.1016/j.semradonc.2013.11.009] [Reference Citation Analysis]
221 Sethi V, Giri B, Saluja A, Dudeja V. Insights into the Pathogenesis of Pancreatic Cystic Neoplasms. Dig Dis Sci 2017;62:1778-86. [PMID: 28500587 DOI: 10.1007/s10620-017-4603-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
222 Durkin C, Krishna SG. Advanced diagnostics for pancreatic cysts: Confocal endomicroscopy and molecular analysis. World J Gastroenterol 2019; 25(22): 2734-2742 [PMID: 31235996 DOI: 10.3748/wjg.v25.i22.2734] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
223 Rastegar N, Matteoni-Athayde LG, Eng J, Takahashi N, Tamm EP, Mortele KJ, Syngal S, Margolis D, Lennon AM, Wolfgang CL, Fishman EK, Hruban RH, Goggins M, Canto MI, Kamel IR. Incremental value of secretin-enhanced magnetic resonance cholangiopancreatography in detecting ductal communication in a population with high prevalence of small pancreatic cysts. Eur J Radiol 2015;84:575-80. [PMID: 25619503 DOI: 10.1016/j.ejrad.2014.12.028] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
224 Gao Y, Cai A, Xi H, Li J, Xu W, Zhang Y, Zhang K, Cui J, Wu X, Wei B, Chen L. Ring finger protein 43 associates with gastric cancer progression and attenuates the stemness of gastric cancer stem-like cells via the Wnt-β/catenin signaling pathway. Stem Cell Res Ther 2017;8:98. [PMID: 28446252 DOI: 10.1186/s13287-017-0548-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
225 Wood LD, Hruban RH. Pathology and molecular genetics of pancreatic neoplasms. Cancer J. 2012;18:492-501. [PMID: 23187835 DOI: 10.1097/ppo.0b013e31827459b6] [Cited by in Crossref: 79] [Cited by in F6Publishing: 43] [Article Influence: 8.8] [Reference Citation Analysis]
226 Ridtitid W, Al-Haddad MA. Endoscopic Ultrasound Imaging for Diagnosing and Treating Pancreatic Cysts. Gastrointest Endosc Clin N Am 2017;27:615-42. [PMID: 28918802 DOI: 10.1016/j.giec.2017.06.004] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
227 Jais B, Rebours V, Malleo G, Salvia R, Fontana M, Maggino L, Bassi C, Manfredi R, Moran R, Lennon AM. Serous cystic neoplasm of the pancreas: a multinational study of 2622 patients under the auspices of the International Association of Pancreatology and European Pancreatic Club (European Study Group on Cystic Tumors of the Pancreas). Gut. 2016;65:305-312. [PMID: 26045140 DOI: 10.1136/gutjnl-2015-309638] [Cited by in Crossref: 156] [Cited by in F6Publishing: 120] [Article Influence: 22.3] [Reference Citation Analysis]
228 Kobayashi T, Omori Y, Ono Y, Karasaki H, Mizukami Y, Makino N, Motoi F, Unno M, Ueno Y, Furukawa T. Pathways for the development of multiple epithelial types of intraductal papillary mucinous neoplasm of the pancreas. J Gastroenterol 2021;56:581-92. [PMID: 33796937 DOI: 10.1007/s00535-021-01783-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
229 Jiang X, Charlat O, Zamponi R, Yang Y, Cong F. Dishevelled promotes Wnt receptor degradation through recruitment of ZNRF3/RNF43 E3 ubiquitin ligases. Mol Cell 2015;58:522-33. [PMID: 25891077 DOI: 10.1016/j.molcel.2015.03.015] [Cited by in Crossref: 86] [Cited by in F6Publishing: 86] [Article Influence: 12.3] [Reference Citation Analysis]
230 Plougmann JI, Klausen P, Toxvaerd A, Abedi AA, Kovacevic B, Karstensen JG, Poulsen TS, Kalaitzakis E, Høgdall E, Vilmann P. DNA sequencing of cytopathologically inconclusive EUS-FNA from solid pancreatic lesions suspicious for malignancy confirms EUS diagnosis. Endosc Ultrasound 2020;9:37-44. [PMID: 31552911 DOI: 10.4103/eus.eus_36_19] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
231 Huang X, Huang K, Johnson T, Radovich M, Zhang J, Ma J, Wang Y. ParsVNN: parsimony visible neural networks for uncovering cancer-specific and drug-sensitive genes and pathways. NAR Genom Bioinform 2021;3:lqab097. [PMID: 34729476 DOI: 10.1093/nargab/lqab097] [Reference Citation Analysis]
232 Matsushita N, Yamamoto S, Inoue Y, Aruga A, Yamamoto M. RT-qPCR analysis of the tumor antigens TOMM34 and RNF43 in samples extracted from paraffin-embedded specimens of colorectal cancer. Oncol Lett 2017;14:2281-7. [PMID: 28789449 DOI: 10.3892/ol.2017.6412] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
233 Dennaoui R, Shrestha H, Wagner KU. Models of pancreatic ductal adenocarcinoma. Cancer Metastasis Rev 2021;40:803-18. [PMID: 34491463 DOI: 10.1007/s10555-021-09989-9] [Reference Citation Analysis]
234 Hayashi H, Kohno T, Ueno H, Hiraoka N, Kondo S, Saito M, Shimada Y, Ichikawa H, Kato M, Shibata T, Morizane C, Sakamoto Y, Shimada K, Komatsu Y, Sakamoto N, Okusaka T. Utility of Assessing the Number of Mutated KRAS, CDKN2A, TP53, and SMAD4 Genes Using a Targeted Deep Sequencing Assay as a Prognostic Biomarker for Pancreatic Cancer. Pancreas 2017;46:335-40. [DOI: 10.1097/mpa.0000000000000760] [Cited by in Crossref: 40] [Cited by in F6Publishing: 28] [Article Influence: 8.0] [Reference Citation Analysis]
235 Yilmaz OH, Deshpande V. Pathology and Genetics of Pancreatic Neoplasms. Surg Pathol Clin 2012;5:941-59. [PMID: 26838509 DOI: 10.1016/j.path.2012.08.008] [Reference Citation Analysis]
236 Kong C, Samovski D, Srikanth P, Wainszelbaum MJ, Charron AJ, Liu J, Lange JJ, Chen PI, Pan ZQ, Su X, Stahl PD. Ubiquitination and degradation of the hominoid-specific oncoprotein TBC1D3 is mediated by CUL7 E3 ligase. PLoS One 2012;7:e46485. [PMID: 23029530 DOI: 10.1371/journal.pone.0046485] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
237 Kisiel JB, Raimondo M, Taylor WR, Yab TC, Mahoney DW, Sun Z, Middha S, Baheti S, Zou H, Smyrk TC, Boardman LA, Petersen GM, Ahlquist DA. New DNA Methylation Markers for Pancreatic Cancer: Discovery, Tissue Validation, and Pilot Testing in Pancreatic Juice. Clin Cancer Res. 2015;21:4473-4481. [PMID: 26023084 DOI: 10.1158/1078-0432.ccr-14-2469] [Cited by in Crossref: 71] [Cited by in F6Publishing: 52] [Article Influence: 10.1] [Reference Citation Analysis]
238 Spit M, Fenderico N, Jordens I, Radaszkiewicz T, Lindeboom RG, Bugter JM, Cristobal A, Ootes L, van Osch M, Janssen E, Boonekamp KE, Hanakova K, Potesil D, Zdrahal Z, Boj SF, Medema JP, Bryja V, Koo BK, Vermeulen M, Maurice MM. RNF43 truncations trap CK1 to drive niche-independent self-renewal in cancer. EMBO J 2020;39:e103932. [PMID: 32965059 DOI: 10.15252/embj.2019103932] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
239 Zhang M, Di CY, Guo P, Meng LB, Shan MJ, Qiu Y, Guo PY, Dong KQ, Xie Q, Wang Q. Screening and Identification of Key Biomarkers in Pancreatic Cancer: Evidence from Bioinformatic Analysis. J Comput Biol 2020;27:1079-91. [PMID: 31638423 DOI: 10.1089/cmb.2019.0189] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
240 Morani AC, Hanafy AK, Ramani NS, Katabathina VS, Yedururi S, Dasyam AK, Prasad SR. Hereditary and Sporadic Pancreatic Ductal Adenocarcinoma: Current Update on Genetics and Imaging. Radiol Imaging Cancer 2020;2:e190020. [PMID: 33778702 DOI: 10.1148/rycan.2020190020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
241 Di Gangi IM, Mazza T, Fontana A, Copetti M, Fusilli C, Ippolito A, Mattivi F, Latiano A, Andriulli A, Vrhovsek U, Pazienza V. Metabolomic profile in pancreatic cancer patients: a consensus-based approach to identify highly discriminating metabolites. Oncotarget 2016;7:5815-29. [PMID: 26735340 DOI: 10.18632/oncotarget.6808] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 8.3] [Reference Citation Analysis]
242 Hao HX, Jiang X, Cong F. Control of Wnt Receptor Turnover by R-spondin-ZNRF3/RNF43 Signaling Module and Its Dysregulation in Cancer. Cancers (Basel) 2016;8:E54. [PMID: 27338477 DOI: 10.3390/cancers8060054] [Cited by in Crossref: 66] [Cited by in F6Publishing: 62] [Article Influence: 11.0] [Reference Citation Analysis]
243 MacDonald BT, He X. A finger on the pulse of Wnt receptor signaling. Cell Res 2012;22:1410-2. [PMID: 22688894 DOI: 10.1038/cr.2012.91] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
244 Ho J, Li X, Zhang L, Liang Y, Hu W, Yau JCW, Chan H, Gin T, Chan MTV, Tse G, Wu WKK. Translational genomics in pancreatic ductal adenocarcinoma: A review with re-analysis of TCGA dataset. Semin Cancer Biol 2019;55:70-7. [PMID: 29705685 DOI: 10.1016/j.semcancer.2018.04.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
245 Gerhard R, Wu RI, Vergara N. Molecular Cytology Applications on Pancreas and Biliary Tract. In: Schmitt FC, editor. Molecular Applications in Cytology. Cham: Springer International Publishing; 2018. pp. 205-22. [DOI: 10.1007/978-3-319-74942-6_11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
246 Thompson ED, Roberts NJ, Wood LD, Eshleman JR, Goggins MG, Kern SE, Klein AP, Hruban RH. The genetics of ductal adenocarcinoma of the pancreas in the year 2020: dramatic progress, but far to go. Mod Pathol 2020;33:2544-63. [PMID: 32704031 DOI: 10.1038/s41379-020-0629-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
247 Wang T, Askan G, Adsay V, Allen P, Jarnagin WR, Memis B, Sigel C, Seven IE, Klimstra DS, Basturk O. Intraductal Oncocytic Papillary Neoplasms: Clinical-Pathologic Characterization of 24 Cases, With An Emphasis on Associated Invasive Carcinomas. Am J Surg Pathol 2019;43:656-61. [PMID: 30986801 DOI: 10.1097/PAS.0000000000001226] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 6.5] [Reference Citation Analysis]
248 Sipos B, Sperveslage J. [Will molecular diagnostics become established in pancreatic pathology?]. Pathologe 2013;34 Suppl 2:214-20. [PMID: 24196616 DOI: 10.1007/s00292-013-1865-z] [Reference Citation Analysis]
249 Haeberle L, Schramm M, Goering W, Frohn L, Driescher C, Hartwig W, Preissinger-Heinzel HK, Beyna T, Neuhaus H, Fuchs K, Keitel-Anselmino V, Knoefel WT, Esposito I. Molecular analysis of cyst fluids improves the diagnostic accuracy of pre-operative assessment of pancreatic cystic lesions. Sci Rep 2021;11:2901. [PMID: 33536452 DOI: 10.1038/s41598-021-81065-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
250 Mas L, Lupinacci RM, Cros J, Bachet JB, Coulet F, Svrcek M. Intraductal Papillary Mucinous Carcinoma Versus Conventional Pancreatic Ductal Adenocarcinoma: A Comprehensive Review of Clinical-Pathological Features, Outcomes, and Molecular Insights. Int J Mol Sci 2021;22:6756. [PMID: 34201897 DOI: 10.3390/ijms22136756] [Reference Citation Analysis]
251 Nikiforova MN, Khalid A, Fasanella KE, McGrath KM, Brand RE, Chennat JS, Slivka A, Zeh HJ, Zureikat AH, Krasinskas AM, Ohori NP, Schoedel KE, Navina S, Mantha GS, Pai RK, Singhi AD. Integration of KRAS testing in the diagnosis of pancreatic cystic lesions: a clinical experience of 618 pancreatic cysts. Mod Pathol. 2013;26:1478-1487. [PMID: 23743931 DOI: 10.1038/modpathol.2013.91] [Cited by in Crossref: 99] [Cited by in F6Publishing: 76] [Article Influence: 11.0] [Reference Citation Analysis]
252 Tsukiyama T, Koo BK, Hatakeyama S. Post-translational Wnt receptor regulation: Is the fog slowly clearing?: The molecular mechanism of RNF43/ZNRF3 ubiquitin ligases is not yet fully elucidated and still controversial. Bioessays 2021;43:e2000297. [PMID: 33569855 DOI: 10.1002/bies.202000297] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
253 Macgregor-Das AM, Iacobuzio-Donahue CA. Molecular pathways in pancreatic carcinogenesis. J Surg Oncol. 2013;107:8-14. [PMID: 22806689 DOI: 10.1002/jso.23213] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 4.8] [Reference Citation Analysis]
254 Kim VM, Ahuja N. Early detection of pancreatic cancer. Chin J Cancer Res 2015;27:321-31. [PMID: 26361402 DOI: 10.3978/j.issn.1000-9604.2015.07.03] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
255 Foulkes R, Ali Asgari M, Curtis A, Hoskins C. Silver-Nanoparticle-Mediated Therapies in the Treatment of Pancreatic Cancer. ACS Appl Nano Mater 2019;2:1758-72. [DOI: 10.1021/acsanm.9b00439] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
256 van Huijgevoort NCM, Del Chiaro M, Wolfgang CL, van Hooft JE, Besselink MG. Diagnosis and management of pancreatic cystic neoplasms: current evidence and guidelines. Nat Rev Gastroenterol Hepatol. 2019;16:676-689. [PMID: 31527862 DOI: 10.1038/s41575-019-0195-x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 29] [Article Influence: 13.7] [Reference Citation Analysis]
257 Panarelli NC, Sela R, Schreiner AM, Crapanzano JP, Klimstra DS, Schnoll-Sussman F, Pochapin MB, Yantiss RK. Commercial molecular panels are of limited utility in the classification of pancreatic cystic lesions. Am J Surg Pathol. 2012;36:1434-1443. [PMID: 22982886 DOI: 10.1097/pas.0b013e31825d534a] [Cited by in Crossref: 29] [Cited by in F6Publishing: 10] [Article Influence: 2.9] [Reference Citation Analysis]
258 Chen JC, Beal EW, Pawlik TM, Cloyd J, Dillhoff ME. Molecular Diagnosis of Cystic Neoplasms of the Pancreas: a Review. J Gastrointest Surg 2020;24:1201-14. [PMID: 32128679 DOI: 10.1007/s11605-020-04537-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
259 Lee H, Lau BT, Ji HP. Targeted Sequencing Strategies in Cancer Research. In: Wu W, Choudhry H, editors. Next Generation Sequencing in Cancer Research. New York: Springer; 2013. pp. 137-63. [DOI: 10.1007/978-1-4614-7645-0_7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
260 Driehuis E, Clevers H. WNT signalling events near the cell membrane and their pharmacological targeting for the treatment of cancer. Br J Pharmacol 2017;174:4547-63. [PMID: 28244067 DOI: 10.1111/bph.13758] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 6.8] [Reference Citation Analysis]
261 Singhi AD, Nikiforova MN, McGrath K. DNA testing of pancreatic cyst fluid: is it ready for prime time? Lancet Gastroenterol Hepatol. 2017;2:63-72. [PMID: 28404017 DOI: 10.1016/s2468-1253(16)30084-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
262 Zou Y, Wang F, Liu FY, Huang MZ, Li W, Yuan XQ, Huang OP, He M. RNF43 mutations are recurrent in Chinese patients with mucinous ovarian carcinoma but absent in other subtypes of ovarian cancer. Gene 2013;531:112-6. [PMID: 24001777 DOI: 10.1016/j.gene.2013.08.054] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
263 Kim JY, Hong S. Precursor Lesions of Pancreatic Cancer. Oncol Res Treat 2018;41:603-10. [DOI: 10.1159/000493554] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
264 Sakamoto H, Kuboki Y, Hatori T, Yamamoto M, Sugiyama M, Shibata N, Shimizu K, Shiratori K, Furukawa T. Clinicopathological significance of somatic RNF43 mutation and aberrant expression of ring finger protein 43 in intraductal papillary mucinous neoplasms of the pancreas. Mod Pathol 2015;28:261-7. [PMID: 25081753 DOI: 10.1038/modpathol.2014.98] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 4.4] [Reference Citation Analysis]
265 Javadinia SA, Shahidsales S, Fanipakdel A, Joudi‐mashhad M, Mehramiz M, Talebian S, Maftouh M, Mardani R, Hassanian SM, Khazaei M, Ferns GA, Avan A. Therapeutic potential of targeting the Wnt/β‐catenin pathway in the treatment of pancreatic cancer. J Cell Biochem 2019;120:6833-40. [DOI: 10.1002/jcb.27835] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
266 Yip-Schneider MT, Wu H, Dumas RP, Hancock BA, Agaram N, Radovich M, Schmidt CM. Vascular endothelial growth factor, a novel and highly accurate pancreatic fluid biomarker for serous pancreatic cysts. J Am Coll Surg. 2014;218:608-617. [PMID: 24491241 DOI: 10.1016/j.jamcollsurg.2013.12.019] [Cited by in Crossref: 52] [Cited by in F6Publishing: 39] [Article Influence: 5.8] [Reference Citation Analysis]
267 Pereira BJA, Oba-Shinjo SM, de Almeida AN, Marie SKN. Molecular alterations in meningiomas: Literature review. Clin Neurol Neurosurg 2019;176:89-96. [PMID: 30553171 DOI: 10.1016/j.clineuro.2018.12.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
268 Qiu W, Yang Z, Fan Y, Zheng Q. ZNRF3 is downregulated in papillary thyroid carcinoma and suppresses the proliferation and invasion of papillary thyroid cancer cells. Tumour Biol 2016;37:12665-72. [PMID: 27448298 DOI: 10.1007/s13277-016-5250-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
269 Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SA, Behjati S, Biankin AV, Bignell GR, Bolli N, Borg A, Børresen-Dale AL. Signatures of mutational processes in human cancer. Nature. 2013;500:415-421. [PMID: 23945592 DOI: 10.1038/nature12477] [Cited by in Crossref: 5380] [Cited by in F6Publishing: 4690] [Article Influence: 597.8] [Reference Citation Analysis]
270 Hong SM, Vincent A, Kanda M, Leclerc J, Omura N, Borges M, Klein AP, Canto MI, Hruban RH, Goggins M. Genome-wide somatic copy number alterations in low-grade PanINs and IPMNs from individuals with a family history of pancreatic cancer. Clin Cancer Res 2012;18:4303-12. [PMID: 22723370 DOI: 10.1158/1078-0432.CCR-12-1075] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
271 Xie VK, He J, Xie K. Protein arginine methylation promotes therapeutic resistance in human pancreatic cancer. Cytokine Growth Factor Rev 2020;55:58-69. [PMID: 32739260 DOI: 10.1016/j.cytogfr.2020.07.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
272 Jun SY, Son D, Kim MJ, Kim SJ, An S, Park YS, Park SR, Choi KD, Jung HY, Kim SC, Yook JH, Kim BS, Hong SM. Heterotopic Pancreas of the Gastrointestinal Tract and Associated Precursor and Cancerous Lesions: Systematic Pathologic Studies of 165 Cases. Am J Surg Pathol 2017;41:833-48. [PMID: 28368927 DOI: 10.1097/PAS.0000000000000850] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
273 Al Efishat MA, Attiyeh MA, Eaton AA, Gönen M, Prosser D, Lokshin AE, Castillo CF, Lillemoe KD, Ferrone CR, Pergolini I, Mino-Kenudson M, Rezaee N, Dal Molin M, Weiss MJ, Cameron JL, Hruban RH, D'Angelica MI, Kingham TP, DeMatteo RP, Jarnagin WR, Wolfgang CL, Allen PJ. Multi-institutional Validation Study of Pancreatic Cyst Fluid Protein Analysis for Prediction of High-risk Intraductal Papillary Mucinous Neoplasms of the Pancreas. Ann Surg 2018;268:340-7. [PMID: 28700444 DOI: 10.1097/SLA.0000000000002421] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
274 Layfield LJ, Ehya H, Filie AC, Hruban RH, Jhala N, Joseph L, Vielh P, Pitman MB. Utilization of ancillary studies in the cytologic diagnosis of biliary and pancreatic lesions: The Papanicolaou Society of Cytopathology Guidelines. Cytojournal. 2014;11:4. [PMID: 25191518 DOI: 10.4103/1742-6413.133352] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
275 Singh H, Mcgrath K, Singhi AD. Novel Biomarkers for Pancreatic Cysts. Dig Dis Sci 2017;62:1796-807. [DOI: 10.1007/s10620-017-4491-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
276 McCarty TR, Paleti S, Rustagi T. Molecular analysis of EUS-acquired pancreatic cyst fluid for KRAS and GNAS mutations for diagnosis of intraductal papillary mucinous neoplasia and mucinous cystic lesions: a systematic review and meta-analysis.Gastrointest Endosc. 2021;93:1019-1033.e5. [PMID: 33359054 DOI: 10.1016/j.gie.2020.12.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
277 Zhang L, Pleskow DK, Turzhitsky V, Yee EU, Berzin TM, Sawhney M, Shinagare S, Vitkin E, Zakharov Y, Khan U, Wang F, Goldsmith JD, Goldberg S, Chuttani R, Itzkan I, Qiu L, Perelman LT. Light scattering spectroscopy identifies the malignant potential of pancreatic cysts during endoscopy. Nat Biomed Eng 2017;1:0040. [PMID: 29057146 DOI: 10.1038/s41551-017-0040] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
278 Brosens LA, Hackeng WM, Offerhaus GJ, Hruban RH, Wood LD. Pancreatic adenocarcinoma pathology: changing “landscape”. J Gastrointest Oncol. 2015;6:358-374. [PMID: 26261723 DOI: 10.3978/j.issn.2078-6891.2015.032] [Cited by in F6Publishing: 22] [Reference Citation Analysis]
279 Loregger A, Grandl M, Mejías-Luque R, Allgäuer M, Degenhart K, Haselmann V, Oikonomou C, Hatzis P, Janssen KP, Nitsche U, Gradl D, van den Broek O, Destree O, Ulm K, Neumaier M, Kalali B, Jung A, Varela I, Schmid RM, Rad R, Busch DH, Gerhard M. The E3 ligase RNF43 inhibits Wnt signaling downstream of mutated β-catenin by sequestering TCF4 to the nuclear membrane. Sci Signal 2015;8:ra90. [PMID: 26350900 DOI: 10.1126/scisignal.aac6757] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 6.4] [Reference Citation Analysis]
280 Vandenbussche CJ, Maleki Z. Fine-needle aspiration of squamous-lined cysts of the pancreas: FNA OF SQUAMOUS LINED CYSTS OF PANCREAS. Diagn Cytopathol 2014;42:592-9. [DOI: 10.1002/dc.23080] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
281 Yu J, Virshup DM. Updating the Wnt pathways. Biosci Rep 2014;34:e00142. [PMID: 25208913 DOI: 10.1042/BSR20140119] [Cited by in Crossref: 55] [Cited by in F6Publishing: 23] [Article Influence: 6.9] [Reference Citation Analysis]
282 Tanaka M. Intraductal Papillary Mucinous Neoplasms of the Pancreas. Pancreas 2014;43:1136-40. [DOI: 10.1097/mpa.0000000000000233] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
283 Park JK, Cho EJ, Ryu JK, Kim YT, Yoon YB. Natural history and malignant risk factors of solid pseudopapillary tumors of the pancreas. Postgrad Med. 2013;125:92-99. [PMID: 23816775 DOI: 10.3810/pgm.2013.03.2634] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
284 Afsar CU, Karabulut M, Karabulut S, Ozal ST, Cikot M, Serilmez M, Tas F. Clinical Significance of Serum NEDD9 Levels in Patients with Pancreatic Cancer. Biomolecules 2018;8:E169. [PMID: 30544746 DOI: 10.3390/biom8040169] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
285 Wang H, Chen Y, Lin P, Li L, Zhou G, Liu G, Logsdon C, Jin J, Abbruzzese JL, Tan TH, Wang H. The CUL7/F-box and WD repeat domain containing 8 (CUL7/Fbxw8) ubiquitin ligase promotes degradation of hematopoietic progenitor kinase 1. J Biol Chem 2014;289:4009-17. [PMID: 24362026 DOI: 10.1074/jbc.M113.520106] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 3.1] [Reference Citation Analysis]
286 Pulvirenti A, Pea A, Chang DK, Jamieson NB. Clinical and Molecular Risk Factors for Recurrence Following Radical Surgery of Well-Differentiated Pancreatic Neuroendocrine Tumors. Front Med (Lausanne) 2020;7:385. [PMID: 32850899 DOI: 10.3389/fmed.2020.00385] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
287 Greer JB, Ferrone CR. Spectrum and Classification of Cystic Neoplasms of the Pancreas. Surg Oncol Clin N Am 2016;25:339-50. [PMID: 27013368 DOI: 10.1016/j.soc.2015.11.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
288 Blaszczak AM, Krishna SG. Endoscopic diagnosis of pancreatic cysts. Curr Opin Gastroenterol 2019;35:448-54. [PMID: 31219827 DOI: 10.1097/MOG.0000000000000558] [Reference Citation Analysis]
289 Singhi AD, Koay EJ, Chari ST, Maitra A. Early Detection of Pancreatic Cancer: Opportunities and Challenges. Gastroenterology. 2019;156:2024-2040. [PMID: 30721664 DOI: 10.1053/j.gastro.2019.01.259] [Cited by in Crossref: 142] [Cited by in F6Publishing: 130] [Article Influence: 47.3] [Reference Citation Analysis]
290 Farrell JJ. Prevalence, Diagnosis and Management of Pancreatic Cystic Neoplasms: Current Status and Future Directions. Gut Liver. 2015;9:571-589. [PMID: 26343068 DOI: 10.5009/gnl15063] [Cited by in Crossref: 83] [Cited by in F6Publishing: 63] [Article Influence: 13.8] [Reference Citation Analysis]
291 Koo BK, van Es JH, van den Born M, Clevers H. Porcupine inhibitor suppresses paracrine Wnt-driven growth of Rnf43; Znrf3-mutant neoplasia. Proc Natl Acad Sci USA. 2015;112:7548-7550. [PMID: 26023187 DOI: 10.1073/pnas.1508113112] [Cited by in Crossref: 89] [Cited by in F6Publishing: 90] [Article Influence: 12.7] [Reference Citation Analysis]
292 Connor AA, Gallinger S. Next generation sequencing of pancreatic ductal adenocarcinoma: right or wrong? Expert Rev Gastroenterol Hepatol 2017;11:683-94. [PMID: 28460572 DOI: 10.1080/17474124.2017.1324296] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
293 Yip-Schneider MT, Wu H, Schmidt CM. Novel expression of vascular endothelial growth factor isoforms in the pancreas and pancreatic cystic lesions. Biochimie 2021;181:234-9. [PMID: 33387563 DOI: 10.1016/j.biochi.2020.12.016] [Reference Citation Analysis]
294 Singhi AD, Chu LC, Tatsas AD, Shi C, Ellison TA, Fishman EK, Kawamoto S, Schulick RD, Wolfgang CL, Hruban RH, Edil BH. Cystic pancreatic neuroendocrine tumors: a clinicopathologic study. Am J Surg Pathol. 2012;36:1666-1673. [PMID: 23073325 DOI: 10.1097/pas.0b013e31826a0048] [Cited by in Crossref: 73] [Cited by in F6Publishing: 24] [Article Influence: 8.1] [Reference Citation Analysis]
295 Zamboni G, Hirabayashi K, Castelli P, Lennon AM. Precancerous lesions of the pancreas. Best Pract Res Clin Gastroenterol. 2013;27:299-322. [PMID: 23809247 DOI: 10.1016/j.bpg.2013.04.001] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
296 Haeberle L, Esposito I. Pathology of pancreatic cancer. Transl Gastroenterol Hepatol. 2019;4:50. [PMID: 31304427 DOI: 10.21037/tgh.2019.06.02] [Cited by in Crossref: 31] [Cited by in F6Publishing: 36] [Article Influence: 10.3] [Reference Citation Analysis]
297 Kulzer M, Singhi AD, Furlan A, Heller MT, Katabathina VS, Mcgrath KM, Zeh HJ, Zureikat A, Dasyam AK. Current concepts in molecular genetics and management guidelines for pancreatic cystic neoplasms: an essential update for radiologists. Abdom Radiol (NY). 2018;43:2351-2368. [PMID: 29404638 DOI: 10.1007/s00261-017-1452-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
298 Fukushima N, Zamboni G. Mucinous cystic neoplasms of the pancreas: Update on the surgical pathology and molecular genetics. Seminars in Diagnostic Pathology 2014;31:467-74. [DOI: 10.1053/j.semdp.2014.08.007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
299 Krug S, Bartsch DK, Schober M, Librizzi D, Pfestroff A, Burbelko M, Moll R, Michl P, Gress TM. Successful selective internal radiotherapy (SIRT) in a patient with a malignant solid pseudopapillary pancreatic neoplasm (SPN). Pancreatology 2012;12:423-7. [PMID: 23127531 DOI: 10.1016/j.pan.2012.07.014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
300 Zhong Z, Sepramaniam S, Chew XH, Wood K, Lee MA, Madan B, Virshup DM. PORCN inhibition synergizes with PI3K/mTOR inhibition in Wnt-addicted cancers. Oncogene 2019;38:6662-77. [DOI: 10.1038/s41388-019-0908-1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 9.3] [Reference Citation Analysis]
301 Makohon-Moore A, Brosnan JA, Iacobuzio-Donahue CA. Pancreatic cancer genomics: insights and opportunities for clinical translation. Genome Med 2013;5:26. [PMID: 23673020 DOI: 10.1186/gm430] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
302 Nasca V, Chiaravalli M, Piro G, Esposito A, Salvatore L, Tortora G, Corbo V, Carbone C. Intraductal Pancreatic Mucinous Neoplasms: A Tumor-Biology Based Approach for Risk Stratification. Int J Mol Sci. 2020;21. [PMID: 32887490 DOI: 10.3390/ijms21176386] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
303 Cooper CL, O'Toole SA, Kench JG. Classification, morphology and molecular pathology of premalignant lesions of the pancreas. Pathology 2013;45:286-304. [PMID: 23442735 DOI: 10.1097/PAT.0b013e32835f2205] [Cited by in Crossref: 40] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
304 Zhong Z, Virshup DM. Wnt Signaling and Drug Resistance in Cancer. Mol Pharmacol. 2020;97:72-89. [PMID: 31787618 DOI: 10.1124/mol.119.117978] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 15.3] [Reference Citation Analysis]
305 Gleeson FC, Levy MJ. The evolving field of genomic biomarkers to characterize pancreatic cystic neoplasia by EUS-guided FNA. Gastrointest Endosc 2016;83:149-50. [PMID: 26227930 DOI: 10.1016/j.gie.2015.07.032] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
306 Molin MD, Matthaei H, Wu J, Blackford A, Debeljak M, Rezaee N, Wolfgang CL, Butturini G, Salvia R, Bassi C, Goggins MG, Kinzler KW, Vogelstein B, Eshleman JR, Hruban RH, Maitra A. Clinicopathological correlates of activating GNAS mutations in intraductal papillary mucinous neoplasm (IPMN) of the pancreas. Ann Surg Oncol. 2013;20:3802-3808. [PMID: 23846778 DOI: 10.1245/s10434-013-3096-1] [Cited by in Crossref: 115] [Cited by in F6Publishing: 90] [Article Influence: 12.8] [Reference Citation Analysis]
307 Paziewska A, Polkowski M, Goryca K, Karczmarski J, Wiechowska-Kozlowska A, Dabrowska M, Mikula M, Ostrowski J. Mutational Mosaics of Cell-Free DNA from Pancreatic Cyst Fluids. Dig Dis Sci 2020;65:2294-301. [PMID: 31925676 DOI: 10.1007/s10620-019-06043-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
308 Macgregor-das A, Goggins M. Diagnostic Biomarkers. In: Neoptolemos JP, Urrutia R, Abbruzzese JL, Büchler MW, editors. Pancreatic Cancer. New York: Springer; 2018. pp. 659-80. [DOI: 10.1007/978-1-4939-7193-0_56] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
309 van Asselt SJ, de Vries EG, van Dullemen HM, Brouwers AH, Walenkamp AM, Giles RH, Links TP. Pancreatic cyst development: insights from von Hippel-Lindau disease. Cilia 2013;2:3. [PMID: 23384121 DOI: 10.1186/2046-2530-2-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
310 van Andel H, Kocemba KA, Spaargaren M, Pals ST. Aberrant Wnt signaling in multiple myeloma: molecular mechanisms and targeting options. Leukemia 2019;33:1063-75. [PMID: 30770859 DOI: 10.1038/s41375-019-0404-1] [Cited by in Crossref: 45] [Cited by in F6Publishing: 52] [Article Influence: 15.0] [Reference Citation Analysis]
311 Fujikura K, Hosoda W, Felsenstein M, Song Q, Reiter JG, Zheng L, Beleva Guthrie V, Rincon N, Dal Molin M, Dudley J, Cohen JD, Wang P, Fischer CG, Braxton AM, Noë M, Jongepier M, Fernández-Del Castillo C, Mino-Kenudson M, Schmidt CM, Yip-Schneider MT, Lawlor RT, Salvia R, Roberts NJ, Thompson ED, Karchin R, Lennon AM, Jiao Y, Wood LD. Multiregion whole-exome sequencing of intraductal papillary mucinous neoplasms reveals frequent somatic KLF4 mutations predominantly in low-grade regions. Gut 2021;70:928-39. [PMID: 33028669 DOI: 10.1136/gutjnl-2020-321217] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
312 Pelosi E, Castelli G, Testa U. Pancreatic Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells. Biomedicines. 2017;5. [PMID: 29156578 DOI: 10.3390/biomedicines5040065] [Cited by in Crossref: 32] [Cited by in F6Publishing: 41] [Article Influence: 6.4] [Reference Citation Analysis]
313 Jiao Y, Yonescu R, Offerhaus GJ, Klimstra DS, Maitra A, Eshleman JR, Herman JG, Poh W, Pelosof L, Wolfgang CL. Whole-exome sequencing of pancreatic neoplasms with acinar differentiation. J Pathol. 2014;232:428-435. [PMID: 24293293 DOI: 10.1002/path.43] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
314 Klöppel G, Basturk O, Schlitter AM, Konukiewitz B, Esposito I. Intraductal neoplasms of the pancreas. Seminars in Diagnostic Pathology 2014;31:452-66. [DOI: 10.1053/j.semdp.2014.08.005] [Cited by in Crossref: 53] [Cited by in F6Publishing: 41] [Article Influence: 6.6] [Reference Citation Analysis]
315 Sano M, Driscoll DR, De Jesus-Monge WE, Klimstra DS, Lewis BC. Activated wnt signaling in stroma contributes to development of pancreatic mucinous cystic neoplasms. Gastroenterology 2014;146:257-67. [PMID: 24067880 DOI: 10.1053/j.gastro.2013.09.044] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
316 Rahmutulla B, Matsushita K, Nomura F. Alternative splicing of DNA damage response genes and gastrointestinal cancers. World J Gastroenterol 2014; 20(46): 17305-17313 [PMID: 25516641 DOI: 10.3748/wjg.v20.i46.17305] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
317 Antonini F, Fuccio L, Fabbri C, Macarri G, Palazzo L. Management of serous cystic neoplasms of the pancreas. Expert Rev Gastroenterol Hepatol. 2015;9:115-125. [PMID: 24981593 DOI: 10.1586/17474124.2014.934675] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
318 Masica DL, Dal Molin M, Wolfgang CL, Tomita T, Ostovaneh MR, Blackford A, Moran RA, Law JK, Barkley T, Goggins M, Irene Canto M, Pittman M, Eshleman JR, Ali SZ, Fishman EK, Kamel IR, Raman SP, Zaheer A, Ahuja N, Makary MA, Weiss MJ, Hirose K, Cameron JL, Rezaee N, He J, Joon Ahn Y, Wu W, Wang Y, Springer S, Diaz LL Jr, Papadopoulos N, Hruban RH, Kinzler KW, Vogelstein B, Karchin R, Lennon AM. A novel approach for selecting combination clinical markers of pathology applied to a large retrospective cohort of surgically resected pancreatic cysts. J Am Med Inform Assoc. 2017;24:145-152. [PMID: 27330075 DOI: 10.1093/jamia/ocw069] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
319 Kakushadze Z, Yu W. Mutation Clusters from Cancer Exome. Genes (Basel) 2017;8:E201. [PMID: 28809811 DOI: 10.3390/genes8080201] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
320 Esposito I, Schlitter A, Sipos B, Klöppel G. Klassifikation und malignes Potenzial der zystischen Pankreastumoren. Pathologe 2015;36:99-114. [DOI: 10.1007/s00292-014-1971-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 1.9] [Reference Citation Analysis]
321 Cheasley D, Wakefield MJ, Ryland GL, Allan PE, Alsop K, Amarasinghe KC, Ananda S, Anglesio MS, Au-Yeung G, Böhm M, Bowtell DDL, Brand A, Chenevix-Trench G, Christie M, Chiew YE, Churchman M, DeFazio A, Demeo R, Dudley R, Fairweather N, Fedele CG, Fereday S, Fox SB, Gilks CB, Gourley C, Hacker NF, Hadley AM, Hendley J, Ho GY, Hughes S, Hunstman DG, Hunter SM, Jobling TW, Kalli KR, Kaufmann SH, Kennedy CJ, Köbel M, Le Page C, Li J, Lupat R, McNally OM, McAlpine JN, Mes-Masson AM, Mileshkin L, Provencher DM, Pyman J, Rahimi K, Rowley SM, Salazar C, Samimi G, Saunders H, Semple T, Sharma R, Sharpe AJ, Stephens AN, Thio N, Torres MC, Traficante N, Xing Z, Zethoven M, Antill YC, Scott CL, Campbell IG, Gorringe KL. The molecular origin and taxonomy of mucinous ovarian carcinoma. Nat Commun 2019;10:3935. [PMID: 31477716 DOI: 10.1038/s41467-019-11862-x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 13.3] [Reference Citation Analysis]
322 Basturk O, Berger MF, Yamaguchi H, Adsay V, Askan G, Bhanot UK, Zehir A, Carneiro F, Hong SM, Zamboni G, Dikoglu E, Jobanputra V, Wrzeszczynski KO, Balci S, Allen P, Ikari N, Takeuchi S, Akagawa H, Kanno A, Shimosegawa T, Morikawa T, Motoi F, Unno M, Higuchi R, Yamamoto M, Shimizu K, Furukawa T, Klimstra DS. Pancreatic intraductal tubulopapillary neoplasm is genetically distinct from intraductal papillary mucinous neoplasm and ductal adenocarcinoma. Mod Pathol 2017;30:1760-72. [PMID: 28776573 DOI: 10.1038/modpathol.2017.60] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 6.8] [Reference Citation Analysis]
323 Singhi AD, McGrath K, Brand RE, Khalid A, Zeh HJ, Chennat JS, Fasanella KE, Papachristou GI, Slivka A, Bartlett DL, Dasyam AK, Hogg M, Lee KK, Marsh JW, Monaco SE, Ohori NP, Pingpank JF, Tsung A, Zureikat AH, Wald AI, Nikiforova MN. Preoperative next-generation sequencing of pancreatic cyst fluid is highly accurate in cyst classification and detection of advanced neoplasia. Gut 2018;67:2131-41. [PMID: 28970292 DOI: 10.1136/gutjnl-2016-313586] [Cited by in Crossref: 143] [Cited by in F6Publishing: 118] [Article Influence: 28.6] [Reference Citation Analysis]
324 Tomishima K, Fujisawa T, Fukumura Y, Ushio M, Sato S, Amano N, Murata A, Tsuzura H, Sato S, Matsumoto K, Shimada Y, Genda T, Isayama H. Mucinous Cystadenocarcinoma of the Pancreas with Cyst Infection in a Male Patient. Intern Med 2020;59:2383-9. [PMID: 32999265 DOI: 10.2169/internalmedicine.4937-20] [Reference Citation Analysis]
325 Huang X, Zhang B, Zhao J, Sun C, Kong K, Deng L, Liu Y, Zheng J. Increased Risk of Second Primary Cancers Following Diagnosis of Malignant Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Population-Based Study. Front Oncol 2019;9:610. [PMID: 31338331 DOI: 10.3389/fonc.2019.00610] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
326 Wang Y, Sundfeldt K, Mateoiu C, Shih IeM, Kurman RJ, Schaefer J, Silliman N, Kinde I, Springer S, Foote M, Kristjansdottir B, James N, Kinzler KW, Papadopoulos N, Diaz LA, Vogelstein B. Diagnostic potential of tumor DNA from ovarian cyst fluid. Elife 2016;5:e15175. [PMID: 27421040 DOI: 10.7554/eLife.15175] [Cited by in Crossref: 24] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
327 Wolfgang CL, Herman JM, Laheru DA, Klein AP, Erdek MA, Fishman EK, Hruban RH. Recent progress in pancreatic cancer. CA Cancer J Clin. 2013;63:318-348. [PMID: 23856911 DOI: 10.1002/caac.21190] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
328 Janin M, Ortiz-Barahona V, de Moura MC, Martínez-Cardús A, Llinàs-Arias P, Soler M, Nachmani D, Pelletier J, Schumann U, Calleja-Cervantes ME, Moran S, Guil S, Bueno-Costa A, Piñeyro D, Perez-Salvia M, Rosselló-Tortella M, Piqué L, Bech-Serra JJ, De La Torre C, Vidal A, Martínez-Iniesta M, Martín-Tejera JF, Villanueva A, Arias A, Cuartas I, Aransay AM, La Madrid AM, Carcaboso AM, Santa-Maria V, Mora J, Fernandez AF, Fraga MF, Aldecoa I, Pedrosa L, Graus F, Vidal N, Martínez-Soler F, Tortosa A, Carrato C, Balañá C, Boudreau MW, Hergenrother PJ, Kötter P, Entian KD, Hench J, Frank S, Mansouri S, Zadeh G, Dans PD, Orozco M, Thomas G, Blanco S, Seoane J, Preiss T, Pandolfi PP, Esteller M. Epigenetic loss of RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a stress adaptive translational program. Acta Neuropathol 2019;138:1053-74. [PMID: 31428936 DOI: 10.1007/s00401-019-02062-4] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 12.3] [Reference Citation Analysis]
329 Ryland GL, Hunter SM, Doyle MA, Caramia F, Li J, Rowley SM, Christie M, Allan PE, Stephens AN, Bowtell DD, Campbell IG, Gorringe KL; Australian Ovarian Cancer Study Group. Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursors. Genome Med 2015;7:87. [PMID: 26257827 DOI: 10.1186/s13073-015-0210-y] [Cited by in Crossref: 90] [Cited by in F6Publishing: 77] [Article Influence: 12.9] [Reference Citation Analysis]
330 Kearns M, Ahmad NA. Diagnosis and Management of Pancreatic Cystic Neoplasms. Curr Treat Options Gastro 2017;15:587-602. [DOI: 10.1007/s11938-017-0162-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
331 Lum L, Clevers H. Cell biology. The unusual case of Porcupine. Science 2012;337:922-3. [PMID: 22923569 DOI: 10.1126/science.1228179] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 4.8] [Reference Citation Analysis]
332 Canakis A, Lee LS. State-of-the-Art Update of Pancreatic Cysts. Dig Dis Sci 2021. [PMID: 34383196 DOI: 10.1007/s10620-021-07084-1] [Reference Citation Analysis]
333 Talabnin C, Janthavon P, Thongsom S, Suginta W, Talabnin K, Wongkham S. Ring finger protein 43 expression is associated with genetic alteration status and poor prognosis among patients with intrahepatic cholangiocarcinoma. Hum Pathol 2016;52:47-54. [PMID: 26980022 DOI: 10.1016/j.humpath.2015.12.027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
334 Noë M, Brosens LA. Pathology of Pancreatic Cancer Precursor Lesions. Surgical Pathology Clinics 2016;9:561-80. [DOI: 10.1016/j.path.2016.05.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
335 Olatunde A, Nigam M, Singh RK, Panwar AS, Lasisi A, Alhumaydhi FA, Jyoti Kumar V, Mishra AP, Sharifi-Rad J. Cancer and diabetes: the interlinking metabolic pathways and repurposing actions of antidiabetic drugs. Cancer Cell Int 2021;21:499. [PMID: 34535145 DOI: 10.1186/s12935-021-02202-5] [Reference Citation Analysis]
336 Bratanic A, Bozic D, Mestrovic A, Martinovic D, Kumric M, Ticinovic Kurir T, Bozic J. Role of endoscopic ultrasound in anticancer therapy: Current evidence and future perspectives. World J Gastrointest Oncol 2021; 13(12): 1863-1879 [DOI: 10.4251/wjgo.v13.i12.1863] [Reference Citation Analysis]
337 Boge M, Gurses B, Vural M, Yilmaz S, Goksel S, Bilge O. Intraductal papillary mucinous neoplasm of the pancreas associated with neuroendocrine tumor: A case report. Int J Surg Case Rep 2017;40:69-72. [PMID: 28942226 DOI: 10.1016/j.ijscr.2017.09.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
338 Tsai J, Liau J, Yuan C, Cheng M, Yuan R, Jeng Y. RNF43 mutation frequently occurs with GNAS mutation and mucin hypersecretion in intraductal papillary neoplasms of the bile duct. Histopathology 2017;70:756-65. [DOI: 10.1111/his.13125] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
339 Reid MD, Saka B, Balci S, Goldblum AS, Adsay NV. Molecular genetics of pancreatic neoplasms and their morphologic correlates: an update on recent advances and potential diagnostic applications. Am J Clin Pathol. 2014;141:168-180. [PMID: 24436263 DOI: 10.1309/ajcp0fkdp7envkev] [Cited by in Crossref: 50] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
340 Xiao S, Ye Z. Pancreatic cystic tumors: an update. Journal of Pancreatology 2018;1:2-18. [DOI: 10.1097/jp9.0000000000000003] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
341 Distler M, Aust D, Weitz J, Pilarsky C, Grützmann R. Precursor lesions for sporadic pancreatic cancer: PanIN, IPMN, and MCN. Biomed Res Int 2014;2014:474905. [PMID: 24783207 DOI: 10.1155/2014/474905] [Cited by in Crossref: 81] [Cited by in F6Publishing: 87] [Article Influence: 10.1] [Reference Citation Analysis]
342 Lin Y, Wu Z, Guo W, Li J. Gene mutations in gastric cancer: a review of recent next-generation sequencing studies. Tumour Biol. 2015;36:7385-7394. [PMID: 26364057 DOI: 10.1007/s13277-015-4002-1] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 5.3] [Reference Citation Analysis]
343 Basturk O, Chung SM, Hruban RH, Adsay NV, Askan G, Iacobuzio-Donahue C, Balci S, Zee SY, Memis B, Shia J, Klimstra DS. Distinct pathways of pathogenesis of intraductal oncocytic papillary neoplasms and intraductal papillary mucinous neoplasms of the pancreas. Virchows Arch 2016;469:523-32. [PMID: 27591765 DOI: 10.1007/s00428-016-2014-x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 5.3] [Reference Citation Analysis]
344 Mattiolo P, Mafficini A, Lawlor RT, Marchegiani G, Malleo G, Pea A, Salvia R, Piccoli P, Sciammarella C, Santonicco N, Parisi A, Silvestris N, Milella M, Adsay V, Scarpa A, Luchini C. "Pure" hepatoid tumors of the pancreas harboring CTNNB1 somatic mutations: a new entity among solid pseudopapillary neoplasms. Virchows Arch 2022. [PMID: 35359182 DOI: 10.1007/s00428-022-03317-4] [Reference Citation Analysis]
345 Wang J, Gerrard G, Poskitt B, Dawson K, Trivedi P, Foroni L, El-Bahrawy M. Targeted next generation sequencing of pancreatic solid pseudopapillary neoplasms show mutations in Wnt signaling pathway genes. Pathol Int 2019;69:193-201. [PMID: 30811747 DOI: 10.1111/pin.12778] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
346 Winter JM, Jiang W, Basturk O, Mino-Kenudson M, Fong ZV, Tan WP, Lavu H, Vollmer CM, Furth EE, Haviland D, Klimstra DS, Jarnagin WR, Lillemoe KD, Yeo CJ, Fernandez-Del Castillo C, Allen PJ. Recurrence and Survival After Resection of Small Intraductal Papillary Mucinous Neoplasm-associated Carcinomas (≤20-mm Invasive Component): A Multi-institutional Analysis. Ann Surg 2016;263:793-801. [PMID: 26135696 DOI: 10.1097/SLA.0000000000001319] [Cited by in Crossref: 40] [Cited by in F6Publishing: 13] [Article Influence: 6.7] [Reference Citation Analysis]
347 Raman A, Lennon AM. Cyst Fluid Biomarkers - Diagnosis and Prediction of Malignancy for Cystic Lesions of the Pancreas. Visc Med 2018;34:178-81. [PMID: 30140682 DOI: 10.1159/000490137] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
348 Takano S, Fukasawa M, Kadokura M, Shindo H, Takahashi E, Hirose S, Maekawa S, Mochizuki K, Kawaida H, Itakura J, Katoh R, Fujii H, Sato T, Enomoto N. Next-Generation Sequencing Revealed TP53 Mutations to Be Malignant Marker for Intraductal Papillary Mucinous Neoplasms That Could Be Detected Using Pancreatic Juice. Pancreas. 2017;46:1281-1287. [PMID: 28930868 DOI: 10.1097/mpa.0000000000000931] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 4.8] [Reference Citation Analysis]
349 Zhu Y, Xu H, Chen H, Xie J, Shi M, Shen B, Deng X, Liu C, Zhan X, Peng C. Proteomic analysis of solid pseudopapillary tumor of the pancreas reveals dysfunction of the endoplasmic reticulum protein processing pathway. Mol Cell Proteomics 2014;13:2593-603. [PMID: 24997997 DOI: 10.1074/mcp.M114.038786] [Cited by in Crossref: 47] [Cited by in F6Publishing: 19] [Article Influence: 5.9] [Reference Citation Analysis]
350 Giri B, Sethi V, Dudeja V, Banerjee S, Livingstone A, Saluja A. Genetics of pancreatic cyst-cancer progression: standing on the shoulders of giants. Curr Opin Gastroenterol 2017;33:404-10. [PMID: 28682795 DOI: 10.1097/MOG.0000000000000382] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
351 Takase Y, Naito Y, Okabe Y, Ishida Y, Yamaguchi T, Abe H, Murata K, Ito T, Tanigawa M, Kawahara A, Yano H, Akiba J. Insulinoma-associated protein 1 expression in pancreatic neuroendocrine tumours in endoscopic ultrasound-guided fine-needle aspiration cytology: An analysis of 14 patients. Cytopathology 2019;30:194-200. [PMID: 30290028 DOI: 10.1111/cyt.12640] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
352 Geisler D, Khader SN. Educational Case: Pancreatic Cystic Disease: A Multimodal Diagnostic Approach to Determine Clinical Management. Academic Pathology 2021;8:237428952199803. [DOI: 10.1177/2374289521998031] [Reference Citation Analysis]
353 Kim M, Karadsheh Z, Levy A, Al-haddad MA. Management of Incidental Pancreatic Cystic Lesions: Integrating Novel Diagnostic and Prognostic Factors With Current Clinical Guidelines. Journal of Clinical Gastroenterology 2020;54:415-27. [DOI: 10.1097/mcg.0000000000001310] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
354 Manfredi R, Ventriglia A, Mantovani W, Mehrabi S, Boninsegna E, Zamboni G, Salvia R, Pozzi Mucelli R. Mucinous cystic neoplasms and serous cystadenomas arising in the body-tail of the pancreas: MR imaging characterization. Eur Radiol. 2015;25:940-949. [PMID: 25417125 DOI: 10.1007/s00330-014-3493-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
355 Elta GH, Enestvedt BK, Sauer BG, Lennon AM. ACG Clinical Guideline: Diagnosis and Management of Pancreatic Cysts. Am J Gastroenterol. 2018;113:464-479. [PMID: 29485131 DOI: 10.1038/ajg.2018.14] [Cited by in Crossref: 174] [Cited by in F6Publishing: 133] [Article Influence: 43.5] [Reference Citation Analysis]
356 Martinez-Font E, Pérez-Capó M, Vögler O, Martín-Broto J, Alemany R, Obrador-Hevia A. WNT/β-Catenin Pathway in Soft Tissue Sarcomas: New Therapeutic Opportunities? Cancers (Basel) 2021;13:5521. [PMID: 34771683 DOI: 10.3390/cancers13215521] [Reference Citation Analysis]
357 Gaujoux S, Parvanescu A, Cesaretti M, Silve C, Bieche I, Rebours V, Lévy P, Sauvanet A, Cros J. GNAS but Not Extended RAS Mutations Spectrum are Associated with a Better Prognosis in Intraductal Pancreatic Mucinous Neoplasms. Ann Surg Oncol 2019;26:2640-50. [DOI: 10.1245/s10434-019-07389-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
358 Pusateri AJ, Krishna SG. Pancreatic Cystic Lesions: Pathogenesis and Malignant Potential. Diseases. 2018;6. [PMID: 29899320 DOI: 10.3390/diseases6020050] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
359 Felsenstein M, Noë M, Masica DL, Hosoda W, Chianchiano P, Fischer CG, Lionheart G, Brosens LAA, Pea A, Yu J, Gemenetzis G, Groot VP, Makary MA, He J, Weiss MJ, Cameron JL, Wolfgang CL, Hruban RH, Roberts NJ, Karchin R, Goggins MG, Wood LD. IPMNs with co-occurring invasive cancers: neighbours but not always relatives. Gut 2018;67:1652-62. [DOI: 10.1136/gutjnl-2017-315062] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 12.8] [Reference Citation Analysis]
360 Harrison G, Hemmerich A, Guy C, Perkinson K, Fleming D, McCall S, Cardona D, Zhang X. Overexpression of SOX11 and TFE3 in Solid-Pseudopapillary Neoplasms of the Pancreas. Am J Clin Pathol. 2017;149:67-75. [PMID: 29272888 DOI: 10.1093/ajcp/aqx142] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
361 Xie W, Liang H, Guo Y, Xiao S. Update on mucinous cystic neoplasm of the pancreas: a narrative review. Journal of Pancreatology 2021;Publish Ahead of Print. [DOI: 10.1097/jp9.0000000000000074] [Reference Citation Analysis]
362 Lennon AM, Canto MI. Pancreatic Cysts - Part 2: Should We Be Less Cyst Centric? Pancreas 2017;46:745-50. [PMID: 28609361 DOI: 10.1097/MPA.0000000000000841] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
363 Hasan N, Ahuja N. The Emerging Roles of ATP-Dependent Chromatin Remodeling Complexes in Pancreatic Cancer. Cancers (Basel) 2019;11:E1859. [PMID: 31769422 DOI: 10.3390/cancers11121859] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
364 Williams RD, Chagtai T, Alcaide-German M, Apps J, Wegert J, Popov S, Vujanic G, van Tinteren H, van den Heuvel-Eibrink MM, Kool M, de Kraker J, Gisselsson D, Graf N, Gessler M, Pritchard-Jones K. Multiple mechanisms of MYCN dysregulation in Wilms tumour. Oncotarget 2015;6:7232-43. [PMID: 25749049 DOI: 10.18632/oncotarget.3377] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 8.5] [Reference Citation Analysis]
365 Pitman MB, Layfield LJ. Guidelines for pancreaticobiliary cytology from the Papanicolaou Society of Cytopathology: A review. Cancer Cytopathol 2014;122:399-411. [PMID: 24777782 DOI: 10.1002/cncy.21427] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 5.9] [Reference Citation Analysis]
366 Reichert M, Blume K, Kleger A, Hartmann D, von Figura G. Developmental Pathways Direct Pancreatic Cancer Initiation from Its Cellular Origin. Stem Cells Int 2016;2016:9298535. [PMID: 26681957 DOI: 10.1155/2016/9298535] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
367 Zhang Q, Chen Y, Bai X, Liang T. Pancreatic cystic neoplasms: current and future approaches to identify patients at risk. Journal of Pancreatology 2019;2:142-6. [DOI: 10.1097/jp9.0000000000000033] [Reference Citation Analysis]
368 Assarzadegan N, Thompson E, Salimian K, Gaida MM, Brosens LAA, Wood L, Ali SZ, Hruban RH. Pathology of intraductal papillary mucinous neoplasms. Langenbecks Arch Surg 2021. [PMID: 34047827 DOI: 10.1007/s00423-021-02201-0] [Reference Citation Analysis]
369 Shain AH, Pollack JR. The spectrum of SWI/SNF mutations, ubiquitous in human cancers. PLoS One. 2013;8:e55119. [PMID: 23355908 DOI: 10.1371/journal.pone.0055119] [Cited by in Crossref: 323] [Cited by in F6Publishing: 293] [Article Influence: 35.9] [Reference Citation Analysis]
370 Rammensee HG, Singh-Jasuja H. HLA ligandome tumor antigen discovery for personalized vaccine approach. Expert Rev Vaccines. 2013;12:1211-1217. [PMID: 24090147 DOI: 10.1586/14760584.2013.836911] [Cited by in Crossref: 71] [Cited by in F6Publishing: 63] [Article Influence: 7.9] [Reference Citation Analysis]
371 Liszka Ł, Pająk J, Gołka D. Serous neoplasms of the pancreas share many, but not all aspects of their microvascular and angiogenic profile with low-grade clear cell renal cell carcinomas. Pathology - Research and Practice 2014;210:901-8. [DOI: 10.1016/j.prp.2014.06.033] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
372 Li S, Lavrijsen M, Bakker A, Magierowski M, Magierowska K, Liu P, Wang W, Peppelenbosch MP, Smits R. Commonly observed RNF43 mutations retain functionality in attenuating Wnt/β-catenin signaling and unlikely confer Wnt-dependency onto colorectal cancers. Oncogene 2020;39:3458-72. [PMID: 32103169 DOI: 10.1038/s41388-020-1232-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
373 Shows J, Bartsch C, Carmichael H, Qureshi I, Edil B, Fenton H. Molecular, Histologic, and Radiologic Findings of High-Grade Invasive Adenocarcinoma Arising in Oncocytic Subtype of Intraductal Papillary Mucinous Neoplasm: A Case Report and Review of Literature. J Pancreat Cancer 2017;3:5-9. [PMID: 28573215 DOI: 10.1089/crpc.2016.0017] [Reference Citation Analysis]
374 McDonald OG, Maitra A, Hruban RH. Human correlates of provocative questions in pancreatic pathology. Adv Anat Pathol 2012;19:351-62. [PMID: 23060061 DOI: 10.1097/PAP.0b013e318273f998] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
375 Yachida S, Iacobuzio-Donahue CA. Evolution and dynamics of pancreatic cancer progression. Oncogene 2013;32:5253-60. [PMID: 23416985 DOI: 10.1038/onc.2013.29] [Cited by in Crossref: 120] [Cited by in F6Publishing: 102] [Article Influence: 13.3] [Reference Citation Analysis]
376 Zhang L, Lum L. Chemical Modulation of WNT Signaling in Cancer. WNT Signaling in Health and Disease. Elsevier; 2018. pp. 245-69. [DOI: 10.1016/bs.pmbts.2017.11.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
377 Li F, Malli A, Cruz-Monserrate Z, Conwell DL, Krishna SG. Confocal endomicroscopy and cyst fluid molecular analysis: Comprehensive evaluation of pancreatic cysts. World J Gastrointest Endosc 2018; 10(1): 1-9 [PMID: 29375735 DOI: 10.4253/wjge.v10.i1.1] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
378 Garcia-Carracedo D, Turk AT, Fine SA, Akhavan N, Tweel BC, Parsons R, Chabot JA, Allendorf JD, Genkinger JM, Remotti HE, Su GH. Loss of PTEN expression is associated with poor prognosis in patients with intraductal papillary mucinous neoplasms of the pancreas. Clin Cancer Res. 2013;19:6830-6841. [PMID: 24132918 DOI: 10.1158/1078-0432.ccr-13-0624] [Cited by in Crossref: 44] [Cited by in F6Publishing: 29] [Article Influence: 4.9] [Reference Citation Analysis]
379 Lee JH, Kim Y, Choi JW, Kim YS. KRAS, GNAS, and RNF43 mutations in intraductal papillary mucinous neoplasm of the pancreas: a meta-analysis. Springerplus. 2016;5:1172. [PMID: 27512631 DOI: 10.1186/s40064-016-2847-4] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 7.2] [Reference Citation Analysis]
380 Assarzadegan N, Babanianmansour S, Shi J. Updates in the Diagnosis of Intraductal Neoplasms of the Pancreas. Front Physiol 2022;13:856803. [DOI: 10.3389/fphys.2022.856803] [Reference Citation Analysis]
381 Selenica P, Raj N, Kumar R, Brown DN, Arqués O, Reidy D, Klimstra D, Snuderl M, Serrano J, Palmer HG, Weigelt B, Reis-Filho JS, Scaltriti M. Solid pseudopapillary neoplasms of the pancreas are dependent on the Wnt pathway. Mol Oncol 2019;13:1684-92. [PMID: 30972907 DOI: 10.1002/1878-0261.12490] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
382 Springer S, Masica DL, Dal Molin M, Douville C, Thoburn CJ, Afsari B, Li L, Cohen JD, Thompson E, Allen PJ, Klimstra DS, Schattner MA, Schmidt CM, Yip-Schneider M, Simpson RE, Fernandez-Del Castillo C, Mino-Kenudson M, Brugge W, Brand RE, Singhi AD, Scarpa A, Lawlor R, Salvia R, Zamboni G, Hong SM, Hwang DW, Jang JY, Kwon W, Swan N, Geoghegan J, Falconi M, Crippa S, Doglioni C, Paulino J, Schulick RD, Edil BH, Park W, Yachida S, Hijioka S, van Hooft J, He J, Weiss MJ, Burkhart R, Makary M, Canto MI, Goggins MG, Ptak J, Dobbyn L, Schaefer J, Sillman N, Popoli M, Klein AP, Tomasetti C, Karchin R, Papadopoulos N, Kinzler KW, Vogelstein B, Wolfgang CL, Hruban RH, Lennon AM. A multimodality test to guide the management of patients with a pancreatic cyst. Sci Transl Med. 2019;11. [PMID: 31316009 DOI: 10.1126/scitranslmed.aav4772] [Cited by in Crossref: 52] [Cited by in F6Publishing: 41] [Article Influence: 26.0] [Reference Citation Analysis]
383 Durante S, Vecchiarelli S, Astolfi A, Grassi E, Casadei R, Santini D, Panzacchi R, Ricci C, Serravalle S, Tarantino G, Falconi M, Teti G, Indio V, Pession A, Minni F, Biasco G, Di Marco M. Copy number gain of chromosome 3q is a recurrent event in patients with intraductal papillary mucinous neoplasm (IPMN) associated with disease progression. Oncotarget 2016;7:74797-806. [PMID: 27566563 DOI: 10.18632/oncotarget.11501] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
384 Shi H, Li J, Fu D. Process of hepatic metastasis from pancreatic cancer: biology with clinical significance. J Cancer Res Clin Oncol 2016;142:1137-61. [PMID: 26250876 DOI: 10.1007/s00432-015-2024-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]